Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3016724	p-hcyst	umol/l (umol/l)	2960	4130	0.02%
3016724	p-hcyst	— (—)	226	251	100.00%	Distribution not available
3016724	p-hcyst	µmol/l (umol/l)	108	127	0.00%
3016724	fp-hcyst	umol/l (umol/l)	101	105	0.00%
3016724	p-hcyst	umol/l____ (umol/l)	28	33	0.00%
3016724	fp-hcyst	— (—)	22	22	100.00%	Distribution not available
3016724	p-homokysteiini	umol/l____ (umol/l)	17	24	0.00%
3016724	homokysteiini	umol/l (umol/l)	11	14	0.00%	Distribution not available
3016724	s-hcyst	µmol/l (umol/l)	8	8	0.00%	Distribution not available	Distribution not available
3016724	p-homokysteiini	umol/l (umol/l)	7	7	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Colitis, primary sclerosing, strict definition

162

146.76

321.75

1.9

1.5

11.19

10.89

umol/l

0.13

162

IBD (strict) with PSC

173

208.20

307.65

2.0

1.5

11.20

10.07

umol/l

0.55

173

Colitis, primary sclerosing

205

115.88

307.65

2.0

1.4

11.16

10.35

umol/l

0.54

205

Ulcerative colitis (strict) with PSC

139

178.71

280.71

2.0

1.6

11.33

10.29

umol/l

0.46

139

Cerebrovascular diseases (FINNGEN)

462

604

5.48

204.01

1.3

1.5

11.97

11.05

umol/l

1.81

452

566

STROKE

629

1064

4.04

193.74

1.2

1.4

12.40

11.79

umol/l

1.22

613

998

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

944

2239

2.87

174.19

1.4

13.69

11.88

umol/l

8.94

907

2107

Anaemias

286

250

7.46

159.89

1.5

1.4

12.69

9.99

umol/l

5.89

278

242

Cerebrovascular diseases

681

1543

3.09

144.26

1.3

1.5

12.86

13.22

umol/l

0.57

656

1443

Stroke, excluding SAH

561

1191

3.44

142.12

1.2

1.5

12.68

13.86

umol/l

3.20

542

1109

Ischaemic Stroke, excluding all haemorrhages

532

1119

3.54

141.60

1.2

1.5

12.68

13.88

umol/l

3.14

516

1041

Hard cardiovascular diseases

755

1562

2.88

135.22

1.4

13.30

11.98

umol/l

4.58

727

1472

Coagulation defects, purpura and other haemorrhagic conditions

289

581

5.10

135.02

1.4

1.5

12.52

12.59

umol/l

0.05

284

541

Stroke, including SAH

577

1286

3.26

134.19

1.2

1.5

12.64

13.67

umol/l

2.65

557

1200

Cardiovascular diseases (excluding rheumatic etc)

626

1184

3.05

122.30

1.4

11.70

10.26

umol/l

6.04

606

1107

Noninfective enteritis and colitis

476

1593

3.02

106.78

1.7

1.4

11.77

12.34

umol/l

1.14

466

1492

Mucosal proctocolitis

205

396

5.32

100.50

1.9

1.4

11.30

12.27

umol/l

1.31

205

368

Malaise and fatigue

470

1236

3.02

99.71

1.4

13.86

12.19

umol/l

3.64

436

1166

IBD patients in KELA-register

294

760

3.94

99.64

1.8

1.4

10.99

12.12

umol/l

2.80

289

714

Inflammatory bowel disease

358

1065

3.41

98.27

1.7

1.4

11.49

12.34

umol/l

1.79

352

1003

Inflammatory bowel disease, strict (require KELA)

294

783

3.82

95.52

1.8

1.4

10.99

12.03

umol/l

2.53

289

736

First line medication for Crohn's disease

880

2130

2.24

92.56

1.5

1.3

12.43

12.14

umol/l

0.54

847

1998

Cardiovascular diseases

539

1015

2.84

91.24

1.4

11.57

10.20

umol/l

4.60

520

949

Sequelae of cerebrovascular disease

317

764

3.59

90.28

1.3

1.5

12.88

14.15

umol/l

2.12

306

707

Venous thromboembolism

459

1595

2.80

89.17

1.4

13.28

13.26

umol/l

0.02

436

1496

Adjustment and management of implanted device

190

383

5.05

88.49

1.5

16.06

13.97

umol/l

2.52

185

346

DVT of lower extremities and pulmonary embolism

361

1210

3.00

80.41

1.4

13.55

13.43

umol/l

0.11

344

1130

Inflammatory bowel disease treatment related agents

880

2342

2.10

79.88

1.5

1.3

12.60

12.15

umol/l

0.99

846

2199

GASTRO-related operations

595

1192

2.52

79.31

1.6

1.3

12.01

11.35

umol/l

1.32

570

1112

Any gastric operation

595

1192

2.52

79.31

1.6

1.3

12.01

11.35

umol/l

1.32

570

1112

ILD medications: immunosuppressive drugs

552

2099

2.40

77.59

1.5

1.4

13.47

11.99

umol/l

4.49

538

1978

Autoimmune diseases related-to ILD

680

2598

2.20

76.76

1.6

1.3

12.22

12.46

umol/l

0.40

660

2438

Examination and observation for other reasons

491

1042

2.68

76.44

1.5

1.4

12.91

12.32

umol/l

0.76

462

988

Persons encountering health services for specific procedures and health care

824

2344

2.09

75.19

1.4

13.62

11.72

umol/l

8.64

786

2213

Pulmonary heart disease, diseases of pulmonary circulation

287

882

3.29

74.81

1.4

13.90

13.49

umol/l

0.40

272

824

Pulmonary embolism

271

809

3.39

74.04

1.4

13.61

13.55

umol/l

0.05

256

753

Pulmonary heart disease

271

810

3.39

73.90

1.4

13.61

13.53

umol/l

0.06

256

754

Reimbursement for rheumatic diseases

469

1922

2.45

70.04

1.6

1.4

12.01

12.50

umol/l

0.85

457

1811

Disorders of gallbladder, biliary tract and pancreas

741

2214

2.09

69.32

1.5

1.4

12.69

12.47

umol/l

0.34

712

2088

Other heart diseases

398

943

2.77

68.71

1.5

13.48

10.54

umol/l

11.42

386

887

General symptoms and signs

770

1846

2.10

68.50

1.4

12.52

11.84

umol/l

1.63

726

1747

Implicit Sepsis, including avohilmo

631

2068

2.19

68.46

1.4

14.55

12.20

umol/l

9.34

597

1954

Heart failure, not strict

551

1602

2.33

67.69

1.5

1.4

16.63

12.10

umol/l

25.39

527

1510

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

686

2196

2.12

67.56

1.4

14.33

11.78

umol/l

12.17

651

2084

Implicit Sepsis

578

1911

2.24

66.64

1.4

14.82

12.39

umol/l

9.22

546

1809

Condition for Implicit Sepsis (Organ dysfunction codes)

650

2111

2.15

66.36

1.5

1.4

14.56

12.04

umol/l

10.76

616

1995

Autoimmune diseases excluding thyroid diseases

767

2029

2.06

66.33

1.5

1.3

12.60

12.48

umol/l

0.18

735

1911

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

370

837

2.81

65.14

1.3

1.5

12.19

10.63

umol/l

4.14

358

786

Fever of other and unknown origin

433

1524

2.48

64.85

1.4

13.29

11.99

umol/l

3.11

420

1442

ILD medications: prednisolone, methylprednisolone, prednisone

802

2238

2.00

64.76

1.4

12.90

12.05

umol/l

2.19

765

2107

Autoimmune diseases excluding thyroid diseases, strict definition

738

1950

2.07

64.71

1.5

1.3

12.60

12.46

umol/l

0.18

706

1834

Heart failure,strict

388

1018

2.68

64.53

1.5

1.4

16.63

12.92

umol/l

13.23

374

949

ILD medications

832

2279

1.98

64.41

1.4

12.84

12.01

umol/l

2.32

796

2147

Heart failure and coronary heart disease

324

777

2.95

64.01

1.5

1.4

17.44

13.91

umol/l

8.71

313

718

Any reimbursement code in KELA

446

863

2.61

63.70

1.5

1.2

11.72

10.05

umol/l

5.24

421

815

169

414

4.16

61.89

1.5

1.4

12.92

11.30

umol/l

2.34

162

396

Implicit bacterial Sepsis

320

987

2.80

61.07

1.4

15.92

13.22

umol/l

5.98

306

922

Dental caries

264

817

3.09

61.00

1.4

14.81

12.21

umol/l

5.10

254

773

Implicit bacterial Sepsis, including avohilmo

346

1076

2.70

60.90

1.4

15.92

13.13

umol/l

6.73

330

1008

Transient ischemic attack

368

1125

2.63

60.87

1.3

1.5

12.75

13.75

umol/l

1.67

354

1043

Used for control exclusion in common control thyroid runs

745

1860

2.03

60.87

1.6

1.3

12.08

12.50

umol/l

0.81

704

1752

Bacterial Sepsis

357

1124

2.65

60.52

1.4

1.5

15.57

13.09

umol/l

5.77

339

1056

Pacemaker

277

873

2.98

60.08

1.6

1.4

15.73

14.19

umol/l

2.45

271

803

Other neurological diseases

522

1834

2.22

59.61

1.3

1.4

12.72

13.08

umol/l

0.50

496

1724

Cardiac arrhythmias

461

1243

2.39

59.61

1.5

1.4

12.86

10.85

umol/l

7.75

444

1183

Diseases of liver

308

1134

2.75

58.43

1.6

1.4

13.77

12.73

umol/l

1.33

294

1070

Heart failure, strict

405

1144

2.48

57.61

1.5

1.4

16.61

13.42

umol/l

10.53

390

1067

Atrial fibrillation and flutter

263

542

3.16

57.02

1.6

1.5

14.37

11.44

umol/l

7.37

254

509

Autoimmune diseases

778

2037

1.95

56.93

1.6

1.3

11.92

12.46

umol/l

1.29

742

1918

Bacterial infection, other or unspecified, including avohilmo

436

1557

2.31

55.32

1.4

14.02

12.58

umol/l

3.48

416

1459

Depression medications

206

269

3.88

54.50

1.4

10.96

10.06

umol/l

1.15

191

261

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

717

2356

1.93

54.22

1.5

1.4

13.83

11.83

umol/l

9.02

685

2231

Hypothyroidism (congenital or acquired)

185

258

4.05

53.98

1.5

1.4

10.42

9.99

umol/l

0.42

174

250

Caries of dentine

230

726

3.09

53.68

1.4

1.5

14.71

12.22

umol/l

4.47

221

688

Persons encountering health services for other counselling and medical advice, not elsewhere classified

771

2170

1.90

52.92

1.4

12.69

12.30

umol/l

0.72

726

2053

Hypothyroidism, levothyroxine purchases

181

253

4.04

52.77

1.5

1.4

10.42

10.05

umol/l

0.34

171

245

Hypothyroidism and >3 levothyroxin purchases

181

253

4.04

52.77

1.5

1.4

10.42

10.05

umol/l

0.34

171

245

Oral corticosteroids

733

2270

1.90

52.02

1.4

12.74

12.19

umol/l

1.16

700

2134

Other ulcerative colitis

167

5.87

51.87

1.8

1.5

11.33

11.86

umol/l

0.36

155

Persons encountering health services in other circumstances, wide

788

2174

1.87

51.57

1.4

12.81

12.30

umol/l

1.03

744

2057

Nutritional anaemias

368

1487

2.38

51.44

1.5

1.4

14.49

12.63

umol/l

3.56

350

1394

Bacterial infection, other or unspecified

391

1422

2.34

51.27

1.4

14.15

12.82

umol/l

2.83

377

1330

Extrapyramidal and movement disorders

298

1158

2.60

50.81

1.7

1.4

14.34

12.99

umol/l

2.24

286

1077

Ulcerative ileocolitis

121

6.80

49.60

1.9

1.5

10.54

11.95

umol/l

1.39

110

Paroxysmal tachycardia

199

515

3.24

48.55

1.5

14.69

11.09

umol/l

8.36

192

484

Anxiety disorders, excluding more controls

585

1906

1.97

47.05

1.4

11.53

12.31

umol/l

1.79

549

1825

Other heart diseases, wide

668

2148

1.89

47.03

1.5

1.4

13.29

11.44

umol/l

8.47

642

2027

Atrial fibrillation and flutter with reimbursement

210

413

3.24

46.98

1.6

1.5

15.69

11.83

umol/l

8.52

203

383

Hypertensive diseases (excluding secondary)

376

925

2.38

46.96

1.4

1.5

13.64

10.48

umol/l

10.35

362

870

Renal failure

327

1162

2.41

46.33

1.4

18.21

13.46

umol/l

13.79

318

1078

Other and unspecified anaemias

298

1133

2.49

45.97

1.5

1.4

16.03

13.46

umol/l

4.86

283

1055

Other anaemias

300

1142

2.48

45.84

1.5

1.4

15.96

13.47

umol/l

4.66

285

1064

Symptoms and signs involving cognition, perception, emotional state and behaviour

667

2422

1.85

44.82

1.3

1.4

13.03

12.23

umol/l

1.73

625

2301

Presence of cardiac and vascular implants and grafts

302

894

2.50

44.67

1.6

1.4

15.79

14.03

umol/l

3.31

292

831

Aplastic and other anaemias

315

1218

2.38

44.07

1.5

1.4

15.90

13.32

umol/l

5.30

300

1135

Implicit viral Sepsis, including avohilmo

235

882

2.68

42.87

1.3

1.4

14.14

12.51

umol/l

2.57

223

827

Care involving use of rehabilitation procedures

439

1935

2.05

42.42

1.4

12.96

12.06

umol/l

1.75

420

1823

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

252

448

2.84

42.30

1.5

1.3

11.85

11.57

umol/l

0.23

237

420

All-cause Heart Failure

362

1121

2.26

42.27

1.5

1.4

16.50

13.48

umol/l

8.46

347

1046

Neurotic, stress-related and somatoform disorders

639

2413

1.83

42.11

1.4

11.35

12.35

umol/l

3.03

597

2297

Anxiety disorders

643

2430

1.82

41.68

1.4

11.35

12.36

umol/l

3.14

601

2313

Tramadol

541

1678

1.95

41.60

1.4

13.57

11.84

umol/l

5.47

519

1578

Phlebitis and thrombophlebitis (not including DVT)

193

666

2.93

41.55

1.3

1.5

12.84

12.59

umol/l

0.19

187

617

Use of pramipexole

180

598

3.05

41.47

1.7

1.4

14.53

12.77

umol/l

2.11

173

555

Other bacterial diseases

639

2325

1.83

41.46

1.4

14.45

12.03

umol/l

10.93

616

2187

Mood disorders, excluding more controls

620

1977

1.85

40.75

1.3

1.4

12.10

12.45

umol/l

0.57

573

1891

Nonischemic cardiomyopathy

105

249

4.29

40.27

1.6

1.5

14.77

13.37

umol/l

1.25

105

228

Anxiety (asthma-related co-morbidities)

463

1774

1.99

40.13

1.4

11.19

11.82

umol/l

1.18

431

1707

Headache

447

1722

2.01

40.03

1.4

11.91

11.67

umol/l

0.28

418

1629

Secondary right heart disease

7.29

39.13

1.6

15.19

15.55

umol/l

0.10

Other bacterial diseases, including avohilmo

683

2430

1.76

38.78

1.4

14.21

11.78

umol/l

11.53

655

2287

Emergency coronary revascularization (for ACS)

550

1772

1.88

38.36

1.5

1.4

14.99

12.40

umol/l

10.42

526

1673

Disorders of thyroid, IBD co-morbidities

154

314

3.39

38.13

1.5

1.4

12.27

11.20

umol/l

0.82

148

294

Implicit viral Sepsis

172

585

2.97

38.05

1.3

1.5

14.83

12.47

umol/l

3.46

162

546

All anxiety disorders

474

1909

1.94

37.98

1.4

11.12

11.88

umol/l

1.60

440

1823

Viral Sepsis

172

586

2.97

37.93

1.3

1.5

14.83

12.46

umol/l

3.48

162

547

Iron deficiency anaemia

297

1291

2.27

37.85

1.4

14.28

12.54

umol/l

2.60

282

1210

Other diseases of intestines

712

2290

1.74

37.71

1.4

12.18

12.14

umol/l

0.06

675

2170

Percutaneous Coronary Intervention

518

1666

1.90

37.22

1.5

1.4

14.94

12.22

umol/l

10.85

495

1571

Other pulmonary heart/vessel disease

6.74

37.11

1.6

15.21

15.79

umol/l

0.18

Medical observation and evaluation for suspected diseases and conditions

424

1051

2.07

37.05

1.5

1.4

12.58

12.37

umol/l

0.22

396

997

Gastrointestinal diseases

389

914

2.14

36.83

1.5

1.3

11.83

11.21

umol/l

0.95

373

862

Metabolic disorders

626

2122

1.78

36.34

1.4

13.09

12.11

umol/l

2.39

594

2004

Coronary revascularization (ANGIO or CABG)

516

1670

1.89

36.26

1.5

1.4

14.90

12.23

umol/l

10.49

493

1575

Endocrine, nutritional and metabolic diseases

532

1430

1.89

35.76

1.5

1.4

12.03

11.45

umol/l

1.00

497

1368

Opioids

637

1866

1.77

35.25

1.4

12.56

11.70

umol/l

2.20

611

1751

Arterial embolism and thrombosis

105

6.02

35.12

1.5

1.6

14.09

13.72

umol/l

0.12

Other and unspecified iron deficiency

241

1016

2.39

34.53

1.4

14.15

12.42

umol/l

2.14

228

953

Heart failure and bmi 25plus

217

556

2.62

34.51

1.4

17.31

13.70

umol/l

6.88

207

515

Pain in throat and chest

560

1839

1.81

34.49

1.4

12.32

11.95

umol/l

0.53

528

1735

Complications of surgical and medical care, not elsewhere classified

647

2518

1.72

34.44

1.4

13.01

12.31

umol/l

1.49

617

2377

Chronic kidney disease

213

817

2.53

34.35

1.4

19.50

13.57

umol/l

12.01

207

749

Abnormalities of breathing

583

1878

1.78

33.91

1.4

13.04

11.92

umol/l

2.96

554

1772

Other anxiety disorders

362

1527

2.03

33.76

1.4

11.27

11.82

umol/l

0.77

337

1463

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

663

2509

1.70

33.59

1.4

12.73

12.23

umol/l

0.83

625

2374

Intestinal infectious diseases

629

2742

1.71

33.59

1.4

13.21

12.19

umol/l

2.26

594

2594

Codes for special purposes

371

1861

1.99

33.57

1.4

13.46

12.16

umol/l

2.83

354

1754

Intestinal infectious diseases, including avohilmo, including avohilmo

736

2469

1.67

33.49

1.4

13.04

12.25

umol/l

1.74

695

2337

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

619

2266

1.73

33.44

1.4

12.93

12.55

umol/l

0.64

591

2137

Mood disorders

673

2558

1.69

33.18

1.3

1.4

11.92

12.42

umol/l

1.03

624

2433

Major coronary heart disease event

532

1762

1.81

33.10

1.5

1.4

14.89

12.27

umol/l

10.64

508

1663

Mood [affective] disorders

671

2556

1.69

33.04

1.3

1.4

11.91

12.42

umol/l

1.03

622

2431

Provisional assignment of new diseases of uncertain etiology

369

1860

1.98

32.95

1.4

13.50

12.16

umol/l

2.97

352

1754

Complications of procedures, not elsewhere classified

531

2416

1.78

32.85

1.4

12.72

12.31

umol/l

0.67

507

2280

Dyspnoea

582

2430

1.73

32.47

1.5

1.4

14.06

12.20

umol/l

6.13

558

2292

Other antidepressants

647

1928

1.72

32.40

1.4

12.24

12.69

umol/l

0.81

602

1839

Dizziness and giddiness

478

2045

1.83

32.09

1.4

13.23

12.40

umol/l

1.40

450

1932

Infections, IBD-co-morbidities

123

251

3.48

31.99

1.5

15.17

11.93

umol/l

3.14

117

233

Depression

634

2513

1.69

31.90

1.3

1.4

11.82

12.36

umol/l

1.11

589

2390

Other noninfective gastroenteritis and colitis

188

736

2.58

31.78

1.6

1.4

12.16

12.70

umol/l

0.49

182

685

Pain in limb

558

2027

1.76

31.65

1.4

12.72

12.34

umol/l

0.57

530

1911

Cardiodefibrillation

222

939

2.38

31.56

1.4

15.05

14.22

umol/l

0.87

211

875

All chronic kidney diseases

351

1402

2.01

31.41

1.4

17.49

12.32

umol/l

16.88

333

1313

Certain infectious and parasitic diseases

606

1753

1.74

31.39

1.5

1.4

12.69

11.80

umol/l

2.19

570

1656

Other soft tissue disorders, not elsewhere classified

624

2090

1.70

31.11

1.4

12.04

12.36

umol/l

0.52

596

1965

Symptoms and signs involving the circulatory and respiratory systems

638

1881

1.71

30.96

1.4

11.94

11.91

umol/l

0.03

606

1775

Renal tubulo-interstitial diseases

554

2350

1.73

30.94

1.4

15.72

11.78

umol/l

20.44

532

2216

Neurological diseases, wide definition

222

442

2.54

30.53

1.5

1.4

11.36

11.14

umol/l

0.17

209

415

Neurological diseases

535

1509

1.79

30.48

1.4

11.84

11.89

umol/l

0.04

502

1438

Ischemic heart diseases

520

1756

1.77

29.91

1.5

1.4

14.45

12.14

umol/l

8.73

499

1653

Other diseases of liver

152

561

2.74

29.05

1.6

1.5

13.28

12.43

umol/l

0.64

144

529

Second line medication for Crohn's disease

397

2157

1.85

29.00

1.4

12.86

12.19

umol/l

1.14

388

2031

All kidney diseases

624

2536

1.65

28.85

1.4

15.14

11.57

umol/l

20.65

600

2396

Continuous positive airway pressure

126

347

3.05

28.12

1.4

1.5

13.82

11.78

umol/l

2.51

121

334

Covid-19 confirmed case

250

1169

2.15

28.10

1.4

14.33

12.79

umol/l

2.50

236

1096

Diarrhoea and gastroenteritis of presumed infectious origin

466

2387

1.75

27.92

1.4

13.26

12.09

umol/l

2.16

439

2263

Statin medication

461

1445

1.80

27.91

1.4

12.30

11.23

umol/l

2.56

443

1361

Pain, not elsewhere classified

202

870

2.34

27.84

1.4

12.99

11.73

umol/l

1.40

188

824

Influenza and pneumonia

674

2593

1.61

27.51

1.4

13.78

11.77

umol/l

8.95

635

2455

Other medical care

289

1195

2.04

27.44

1.3

1.4

14.00

12.76

umol/l

1.75

274

1113

Exposure to unspecified factor

650

2747

1.61

27.44

1.4

12.42

12.33

umol/l

0.11

612

2601

Syncope and collapse

273

1100

2.08

27.38

1.3

1.4

14.19

12.49

umol/l

2.60

255

1035

Acquired haemolytic anaemia

7.88

27.35

1.8

1.6

15.69

13.25

umol/l

0.64

Chronic hepatitis, not elsewhere classified

5.79

27.06

2.0

1.6

12.04

12.69

umol/l

0.23

Visual disturbances and blindness

343

1820

1.89

27.06

1.3

1.4

11.83

12.64

umol/l

1.36

325

1712

Non-ischemic cardiomyopathy

196

656

2.39

26.95

1.5

1.4

15.38

13.59

umol/l

2.41

189

611

Other functional intestinal disorders

293

1336

2.00

26.85

1.5

1.4

12.52

12.67

umol/l

0.12

282

1260

Congenital malformations, deformations and chromosomal abnormalities

410

2181

1.79

26.83

1.3

1.4

11.07

11.87

umol/l

1.77

394

2065

Pain (limb, back, neck, head abdominally)

446

1237

1.81

26.74

1.5

1.3

12.82

12.46

umol/l

0.44

425

1157

Any mental disorder

649

2001

1.63

26.66

1.4

12.28

12.47

umol/l

0.26

613

1913

Polyneuropathies and other disorders of the peripheral nervous system

159

628

2.56

26.56

1.2

1.5

14.14

13.38

umol/l

0.49

147

588

Bleeding

498

2056

1.70

26.08

1.4

14.01

12.72

umol/l

3.00

473

1944

Visual disturbances

323

1705

1.91

26.02

1.3

1.4

11.81

12.65

umol/l

1.33

306

1603

Complications of medical and surgical care

461

2420

1.72

25.97

1.4

12.86

12.46

umol/l

0.56

439

2282

Diseases of oesophagus, stomach and duodenum

654

2420

1.60

25.95

1.4

12.89

12.17

umol/l

1.63

616

2294

Any death

376

1436

1.84

25.50

1.4

15.00

13.28

umol/l

3.38

354

1350

Oedema, not elsewhere classified

202

885

2.24

25.21

1.4

13.62

12.30

umol/l

1.42

189

834

Migraine

346

1448

1.87

25.15

1.3

1.4

10.72

11.62

umol/l

1.61

322

1381

Haemolytic anaemias

5.93

25.03

2.2

1.6

15.27

13.37

umol/l

0.54

Hypothyroidism, strict autoimmune

415

1535

1.78

25.02

1.5

1.3

11.29

12.55

umol/l

2.91

394

1440

Other arrhythmias

405

1706

1.78

25.00

1.4

13.18

11.70

umol/l

3.81

389

1607

Antihypertensive medication - note that there are other indications

419

1220

1.80

24.91

1.4

11.84

10.32

umol/l

4.59

394

1164

Disorders of the thyroid gland

567

2262

1.63

24.79

1.5

1.4

11.54

12.66

umol/l

3.47

542

2138

Abdominal and pelvic pain

594

1833

1.63

24.65

1.5

1.3

12.20

12.46

umol/l

0.39

566

1728

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

437

2328

1.72

24.64

1.3

1.4

11.11

11.99

umol/l

2.08

417

2206

Abnormalities of heart beat

236

1102

2.09

24.59

1.4

12.15

12.27

umol/l

0.09

229

1037

Pneumonia, organism unspecified

574

2440

1.62

24.59

1.4

14.22

11.85

umol/l

9.31

540

2310

Symptoms and signs involving the digestive system and abdomen

594

1833

1.63

24.45

1.5

1.3

12.35

12.46

umol/l

0.13

565

1728

L04AX Other immunosuppressants

372

2092

1.79

24.41

1.4

13.00

12.21

umol/l

1.37

363

1971

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

554

1985

1.64

24.05

1.4

13.84

11.81

umol/l

7.14

522

1875

554

1985

1.64

24.05

1.4

13.84

11.81

umol/l

7.14

522

1875

Symptoms and signs involving the skin and subcutaneous tissue

453

2548

1.68

23.99

1.4

11.86

12.49

umol/l

1.19

437

2400

Recurrent or chronic depression

273

948

2.01

23.97

1.3

1.4

12.16

12.19

umol/l

0.02

257

915

All pneumoniae

637

2641

1.57

23.93

1.4

13.98

11.80

umol/l

9.52

601

2500

Episodal and paroxysmal disorders

654

2109

1.58

23.71

1.3

1.4

11.68

12.42

umol/l

1.87

615

2006

Total colectomy

128

4.57

23.70

1.6

1.5

11.89

12.14

umol/l

0.12

119

Total colectomy operation

128

4.57

23.70

1.6

1.5

11.89

12.14

umol/l

0.12

119

Disturbances of skin sensation

210

988

2.14

23.47

1.3

1.4

11.23

11.91

umol/l

0.81

199

930

Other reaction to severe stress, and adjustment disorders

259

1315

1.98

23.43

1.4

11.82

11.59

umol/l

0.17

243

1257

Pneumonias (Asthma/COPD co-morbidities)

631

2639

1.57

23.39

1.4

14.00

11.82

umol/l

9.45

595

2498

Other and unspecified polyneuropathies, also in other diseases

139

548

2.56

23.38

1.3

1.5

14.20

13.42

umol/l

0.49

128

511

Oxycodone

235

977

2.07

23.32

1.4

13.30

12.80

umol/l

0.49

225

911

Explicit Sepsis, including avohilmo

265

1225

1.97

23.29

1.4

14.19

12.64

umol/l

2.66

254

1151

Explicit Sepsis

260

1202

1.98

23.18

1.4

14.08

12.68

umol/l

2.26

249

1131

Hypothyroidism, other/unspecified

520

2100

1.63

22.97

1.5

1.3

11.36

12.58

umol/l

3.42

498

1983

Persons encountering health services for specific procedures, not carried out

269

3.28

22.90

1.1

1.5

14.54

11.31

umol/l

2.20

249

Septicaemia

247

1129

2.00

22.82

1.4

14.36

12.95

umol/l

2.18

237

1051

Other symptoms and signs involving cognitive functions and awareness

271

1252

1.93

22.29

1.3

1.4

13.55

13.32

umol/l

0.17

251

1178

Chronic Coagulation defects

5.92

22.10

1.3

1.5

12.40

10.63

umol/l

1.02

Other disorders of fluid, electrolyte and acid-base balance

185

795

2.20

22.07

1.3

1.4

15.80

13.29

umol/l

2.60

172

741

Nausea and vomiting

177

779

2.23

21.85

1.4

1.3

13.99

12.46

umol/l

1.36

170

727

General examination and investigation of persons without complaint and reported diagnosis

363

1048

1.80

21.78

1.5

1.4

12.47

12.33

umol/l

0.15

346

994

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

611

2635

1.55

21.68

1.4

14.08

11.85

umol/l

8.98

578

2494

Ulcer of lower limb, not elsewhere classified

106

379

2.83

21.65

1.4

1.5

17.03

13.72

umol/l

3.29

349

Symptoms and signs involving the nervous and musculoskeletal systems

354

2035

1.75

21.62

1.3

1.4

13.35

12.46

umol/l

1.33

331

1924

Subjective visual disturbances

181

832

2.19

21.51

1.4

11.97

12.38

umol/l

0.28

171

780

Codeine

541

1832

1.60

21.22

1.3

1.4

12.68

11.70

umol/l

2.21

516

1718

Diseases of arteries, arterioles and capillaries

370

1567

1.74

21.11

1.4

14.46

13.37

umol/l

1.62

350

1471

Hypothyreosis and Thyroxine purchase for inclusion criteria

534

2212

1.59

20.98

1.5

1.3

11.40

12.59

umol/l

3.33

512

2084

Hypertensive diseases

491

1706

1.63

20.86

1.4

13.95

11.38

umol/l

9.79

469

1614

Hypertension

489

1704

1.62

20.54

1.4

13.95

11.38

umol/l

9.70

467

1612

Depression or dysthymia

379

1192

1.74

20.52

1.3

1.4

12.30

12.73

umol/l

0.50

358

1144

Abnormal findings on examination of blood, without diagnosis

281

1384

1.85

20.36

1.5

1.4

13.47

13.43

umol/l

0.03

269

1298

Cholelithiasis, broad definition with cholecystitis

488

2027

1.61

20.35

1.4

13.37

12.49

umol/l

1.58

465

1908

Benign neoplasm: Colon

301

1579

1.80

20.10

1.4

13.65

13.56

umol/l

0.07

284

1483

Pain in joint

348

1219

1.76

20.05

1.4

1.3

12.37

12.39

umol/l

0.02

329

1143

Chronic gastritis

162

741

2.20

19.52

1.4

14.75

13.56

umol/l

0.83

149

692

Other diseases of the digestive system

190

925

2.07

19.47

1.5

1.4

14.49

13.59

umol/l

0.85

185

860

Disorders of lipoprotein metabolism and other lipidaemias

469

1775

1.61

19.45

1.3

1.4

13.00

12.55

umol/l

0.69

440

1674

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

356

2072

1.69

19.36

1.4

12.88

12.58

umol/l

0.33

340

1953

Certain infectious and parasitic diseases, including avohilmo

413

1235

1.68

19.31

1.5

1.4

12.29

12.10

umol/l

0.20

390

1160

Persons encountering health services for examination and investigation

363

1051

1.74

19.14

1.5

1.4

12.47

12.37

umol/l

0.09

335

997

Haemorrhage from respiratory passages

197

861

2.03

19.00

1.5

1.4

14.11

13.30

umol/l

0.73

185

809

Diseases of the digestive system

266

1455

1.82

18.84

1.4

13.89

13.21

umol/l

0.76

257

1364

Benzodiazepine use

597

2683

1.51

18.79

1.5

1.4

12.56

12.40

umol/l

0.20

551

2549

Gout

167

667

2.16

18.73

1.3

1.5

18.17

14.31

umol/l

5.67

153

626

Psychiatric diseases

551

1784

1.55

18.70

1.4

12.45

12.51

umol/l

0.07

514

1711

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

331

1952

1.70

18.37

1.4

12.86

12.61

umol/l

0.25

316

1837

Cholelithiasis

459

1979

1.59

18.36

1.4

13.35

12.46

umol/l

1.52

436

1860

Diseases of the eye and adnexa

492

1561

1.58

18.28

1.4

11.89

12.07

umol/l

0.21

463

1488

Other septicaemia, including avohilmo

215

1046

1.94

18.28

1.4

14.52

13.03

umol/l

2.09

210

972

Constipation

513

2255

1.55

18.25

1.5

1.4

12.85

12.59

umol/l

0.32

482

2134

Gout, FINNGEN

167

791

2.11

18.12

1.3

1.4

18.17

14.35

umol/l

5.67

153

738

Irritable bowel syndrome

181

894

2.04

17.90

1.3

1.4

11.01

11.92

umol/l

1.06

165

843

Benign neoplasm of colon, rectum, anus and anal canal

346

1750

1.68

17.90

1.4

13.62

13.42

umol/l

0.18

325

1645

Nonorganic sleeping disorders, excluding more controls

143

645

2.23

17.90

1.4

10.88

12.01

umol/l

0.93

134

612

Osteoporosis

151

636

2.19

17.85

1.5

1.4

13.78

13.29

umol/l

0.33

146

597

Hernia of abdominal wall, postoperative

109

435

2.50

17.68

1.3

14.93

12.47

umol/l

2.39

103

399

Osteopathies and chondropathies

332

1810

1.68

17.61

1.5

1.4

13.90

12.49

umol/l

2.54

317

1708

Special screening examination for infectious and parasitic diseases

176

617

2.09

17.61

1.3

10.53

11.42

umol/l

1.12

159

588

Other diseases of blood and blood-forming organs, wide

147

676

2.19

17.57

1.3

1.5

13.12

12.86

umol/l

0.16

140

631

Hyperlipidaemia, other/unspecified

209

978

1.93

17.43

1.2

1.5

14.24

13.61

umol/l

0.56

200

911

Symptoms and signs involving speech and voice

207

1083

1.92

17.37

1.4

12.28

12.56

umol/l

0.25

197

1018

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

218

1162

1.89

17.29

1.4

12.31

12.14

umol/l

0.13

212

1096

Gout, idiopatic and unspecified

147

681

2.17

17.24

1.3

1.4

18.35

14.09

umol/l

5.85

134

632

Gout, unspecified

126

548

2.32

17.22

1.2

1.4

18.68

14.12

umol/l

5.53

115

503

Follow-up examination after treatment for conditions other than malignant neoplasms

244

877

1.86

17.20

1.4

11.97

12.43

umol/l

0.48

230

831

Other bacterial intestinal infections, including avohilmo

147

683

2.17

17.12

1.5

1.4

14.29

12.90

umol/l

1.07

141

640

Paralytic ileus and intestinal obstruction

147

683

2.16

17.06

1.5

1.4

14.29

13.36

umol/l

0.71

140

634

Arterial embolism and thrombosis of lower extremity artery

5.33

17.05

1.3

1.6

14.00

14.81

umol/l

0.22

Migraine with aura

172

849

2.04

17.05

1.3

1.5

11.28

11.22

umol/l

0.04

162

814

Other disorders of skin and subcutaneous tissue

415

2225

1.58

16.88

1.4

13.28

12.58

umol/l

1.12

397

2094

Selective serotonin reuptake inhibitors

560

1938

1.51

16.83

1.4

12.06

12.68

umol/l

1.16

524

1849

Factors influencing health status and contact with health services

167

387

2.17

16.79

1.6

1.3

13.29

12.07

umol/l

1.27

157

367

Asthma, excluding more controls

431

1404

1.58

16.04

1.3

1.4

12.56

11.40

umol/l

2.36

413

1329

Thyrotoxicosis

159

784

2.04

15.88

1.4

1.5

12.65

11.96

umol/l

0.53

153

736

Other arterial embolism and thrombosis

5.28

15.86

1.6

13.66

14.16

umol/l

0.11

Hypertension, essential

451

1650

1.55

15.76

1.3

1.4

13.51

11.45

umol/l

6.73

430

1560

Gout, strict definition

111

477

2.35

15.65

1.3

1.4

17.89

14.37

umol/l

3.77

100

437

Organic, including symptomatic, mental disorders

254

1011

1.77

15.60

1.6

1.4

14.56

13.97

umol/l

0.56

237

938

Pure hypercholesterolaemia

407

1651

1.57

15.42

1.3

1.4

13.56

12.66

umol/l

1.40

379

1553

COPD/asthma/ILD related infections

579

1985

1.46

15.14

1.4

12.74

11.81

umol/l

2.00

542

1875

COPD/asthma related infections

579

1985

1.46

15.14

1.4

12.74

11.81

umol/l

2.00

542

1875

Codeine or tramadol medication

641

2439

1.43

15.08

1.3

1.4

12.80

12.12

umol/l

1.47

608

2298

Fall on same level

665

2502

1.42

14.96

1.4

13.25

11.84

umol/l

4.75

625

2376

Intestinal stricture

173

898

1.94

14.94

1.4

14.53

13.33

umol/l

1.11

164

839

Unspecified jaundice

108

3.94

14.69

1.7

1.4

11.83

14.22

umol/l

1.68

Asthma, unspecified (mode), excluding more controls

300

1301

1.65

14.47

1.3

1.4

13.06

11.44

umol/l

2.95

288

1236

Neoplasms

466

1620

1.51

14.45

1.4

11.59

11.93

umol/l

0.48

439

1537

Iron deficiency anaemia secondary to blood loss (chronic)

414

2.38

14.40

1.5

14.59

12.94

umol/l

1.01

384

Procreative management

228

1065

1.77

14.39

1.7

1.4

10.56

11.82

umol/l

2.89

221

1014

Dysphagia

142

699

2.04

14.29

1.4

1.3

12.43

13.19

umol/l

0.66

130

654

Immunodeficiencies

134

3.57

14.21

1.3

1.5

11.25

11.60

umol/l

0.16

123

Other bacterial intestinal infections

110

493

2.25

14.10

1.5

1.4

15.07

13.00

umol/l

1.54

105

455

Asthma (only as main-diagnosis), excluding more controls

394

1404

1.56

14.03

1.3

1.4

12.41

11.40

umol/l

1.90

379

1329

Malignant neoplasm, including Hilmo

502

1990

1.47

13.99

1.4

11.88

12.42

umol/l

0.98

487

1881

Malignant neoplasm, wide definition

501

1991

1.47

13.76

1.4

11.89

12.39

umol/l

0.89

485

1881

Disorders of other endocrine glands

258

1525

1.67

13.65

1.5

1.4

11.91

12.14

umol/l

0.18

249

1444

Other disorders of urethra and urinary system

382

1730

1.54

13.64

1.4

13.05

12.14

umol/l

1.40

358

1635

Major coronary heart disease event excluding revascularizations

295

1191

1.64

13.55

1.5

1.4

15.79

13.23

umol/l

5.26

270

1117

Cardiac arrest

3.72

13.33

1.9

1.6

15.16

13.48

umol/l

0.77

Other disorders of veins

227

1313

1.71

13.05

1.4

12.87

12.30

umol/l

0.63

219

1232

Cystitis

454

1831

1.48

12.99

1.4

12.15

12.21

umol/l

0.06

423

1731

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

158

723

1.92

12.98

1.3

1.4

9.94

10.61

umol/l

0.80

149

687

Dementia

195

738

1.81

12.92

1.7

1.4

14.97

14.61

umol/l

0.24

182

681

Benign neoplasms

567

2178

1.42

12.91

1.4

12.23

12.30

umol/l

0.09

538

2064

Coronary atherosclerosis

321

1278

1.59

12.90

1.6

1.4

15.40

12.96

umol/l

5.52

299

1200

Other special examinations and investigations of persons without complaint or reported diagnosis

330

1051

1.59

12.86

1.4

12.43

12.37

umol/l

0.05

312

997

Hyperkinetic disorders, excluding more controls

358

2.36

12.83

1.3

1.5

9.69

10.31

umol/l

0.48

349

Asthma

438

1518

1.49

12.74

1.3

1.4

12.66

11.80

umol/l

1.44

420

1437

Parasetamol

426

1438

1.50

12.72

1.4

12.85

11.47

umol/l

3.25

400

1355

Somatoform disorder

109

514

2.14

12.39

1.3

1.4

10.09

12.03

umol/l

3.33

102

492

Migraine without aura

137

705

1.95

12.25

1.3

1.4

10.32

10.68

umol/l

0.22

127

678

Erysipelas

287

1562

1.59

12.22

1.4

15.22

12.78

umol/l

5.29

274

1464

Abnormal serum enzyme levels

165

870

1.84

12.19

1.5

1.4

13.54

14.24

umol/l

0.57

155

805

Streptococcal septicaemia, including avohilmo

234

2.72

12.18

1.3

1.5

14.16

13.04

umol/l

0.54

212

Other external causes of accidental injury

443

1509

1.47

12.12

1.4

12.55

11.86

umol/l

1.15

414

1437

All influenza

150

800

1.88

12.04

1.4

15.02

12.80

umol/l

2.60

143

757

Other diseases of urinary system

534

2124

1.41

12.01

1.4

12.70

12.34

umol/l

0.51

501

2013

Other headache syndromes

235

1423

1.65

11.99

1.3

1.4

10.88

12.16

umol/l

2.82

219

1356

Use of rivastigmine

323

2.42

11.97

1.9

1.4

15.27

15.20

umol/l

0.02

297

Dementia, including avohilmo

206

810

1.74

11.94

1.7

1.4

15.59

14.44

umol/l

1.05

194

751

Bacterial intestinal infections, IBD co-morbidities

108

515

2.11

11.94

1.5

1.4

15.18

12.82

umol/l

1.86

103

474

Intracranial trauma

290

1235

1.59

11.91

1.4

12.06

11.91

umol/l

0.15

274

1175

Other diseases of anus and rectum

162

887

1.83

11.83

1.3

1.4

13.20

12.88

umol/l

0.22

152

831

Asthma, unspecified (mode)

304

1406

1.56

11.80

1.3

1.4

13.10

11.87

umol/l

1.88

292

1335

Peripheral artery disease

202

926

1.73

11.78

1.4

15.72

14.19

umol/l

1.62

192

862

Asthma (mode)

426

1525

1.47

11.66

1.3

1.4

12.45

11.82

umol/l

0.92

409

1444

Accidents

440

1509

1.46

11.66

1.4

12.52

11.86

umol/l

1.07

411

1437

Myocardial infarction

233

980

1.67

11.62

1.5

1.4

16.24

13.30

umol/l

5.18

212

915

Erysipelas, including avohilmo

380

1902

1.48

11.60

1.4

14.98

12.30

umol/l

7.57

364

1789

Streptococcal septicaemia

229

2.69

11.58

1.3

1.4

14.09

13.05

umol/l

0.48

208

Generalized anxiety disorder

113

554

2.05

11.57

1.6

1.5

9.67

11.22

umol/l

2.45

102

532

Personality disorders, excluding more controls

156

852

1.84

11.56

1.3

1.4

12.15

11.68

umol/l

0.31

140

820

Diaphragmatic hernia

189

1102

1.72

11.31

1.5

1.4

13.74

13.14

umol/l

0.52

178

1038

Soft tissue disorders

569

2106

1.39

11.25

1.4

11.74

12.37

umol/l

1.39

550

1980

Hypothyroidism, strict autoimmune, 3 medication purchases required

441

2069

1.43

11.17

1.5

1.3

11.14

12.56

umol/l

4.12

419

1952

Asthma (only as main-diagnosis)

399

1518

1.47

11.17

1.3

1.4

12.47

11.80

umol/l

1.02

384

1437

Explicit bacterial Sepsis

269

2.51

11.11

1.4

1.5

13.54

13.27

umol/l

0.11

244

Disorders of conjunctiva

477

2632

1.41

11.08

1.4

11.48

12.27

umol/l

1.65

451

2490

Injuries to the head

623

2734

1.35

10.98

1.4

13.30

12.16

umol/l

3.19

585

2591

Explicit bacterial Sepsis, including avohilmo

283

2.46

10.94

1.4

1.5

13.62

13.22

umol/l

0.17

256

Excluding asthma or asthma-COPD overlap

440

1529

1.44

10.94

1.5

1.4

12.84

11.80

umol/l

2.13

414

1448

Other pulmonary diagnosis

440

1529

1.44

10.94

1.4

12.71

11.80

umol/l

1.76

414

1448

ILD differential diagnosis

439

1525

1.45

10.93

1.5

1.4

12.83

11.82

umol/l

2.01

413

1444

Conjunctivitis

440

2497

1.42

10.91

1.4

11.30

12.08

umol/l

1.55

416

2364

Nonorganic sleeping disorders

143

779

1.85

10.82

1.4

10.88

11.55

umol/l

0.46

134

739

Cerebral cysts

170

2.92

10.82

1.1

1.6

10.47

12.19

umol/l

1.54

155

Speech therapy

143

780

1.84

10.77

1.4

12.64

12.83

umol/l

0.13

135

730

Autoimmune hepatitis

13.46

10.76

2.0

1.8

11.17

10.87

umol/l

0.09

COPD differential diagnosis

438

1526

1.44

10.75

1.5

1.4

12.84

11.82

umol/l

2.07

412

1445

Congenital varicose veins

15.47

10.72

1.1

1.4

8.84

10.01

umol/l

0.36

Polyarthropathies

386

1701

1.46

10.69

1.3

1.4

14.37

12.10

umol/l

6.20

361

1607

Nonpyogenic thrombosis of intracranial venous system

11.71

10.67

2.5

2.1

11.57

12.21

umol/l

0.10

Falls/tendency to fall

594

2187

1.36

10.58

1.5

1.4

12.77

11.78

umol/l

2.78

565

2078

615

2306

1.35

10.54

1.4

12.86

12.21

umol/l

1.27

585

2168

Other gastritis (incl. Duodenitis)

124

655

1.90

10.35

1.5

1.4

14.93

13.26

umol/l

1.33

116

612

Functional dyspepsia

156

886

1.77

10.30

1.4

12.13

12.33

umol/l

0.13

150

833

Cholecystectomy

365

2140

1.45

10.26

1.4

13.69

12.45

umol/l

2.07

346

2013

Benign neoplasm of other and ill-defined parts of digestive system

100

492

2.05

10.25

1.4

1.5

12.68

13.10

umol/l

0.23

460

Diseases of the skin and subcutaneous tissue

531

1935

1.38

10.21

1.4

12.60

12.28

umol/l

0.44

493

1838

Thrombotic microangiopathy

15.51

10.16

1.5

15.19

10.73

umol/l

1.20

Other degenerative diseases of the nervous system

125

477

1.92

10.11

1.4

13.96

13.36

umol/l

0.30

117

449

Acute bronchitis

221

1357

1.60

10.06

1.4

13.54

12.53

umol/l

1.34

214

1279

Malignant neoplasm

466

1955

1.40

10.05

1.4

11.90

12.39

umol/l

0.84

450

1847

Valvular heart disease excluding rheumatic fever

227

1009

1.61

10.04

1.4

14.84

12.62

umol/l

3.88

221

946

Other extrapyramidal and movement disorders in other diseases

134

733

1.84

10.04

1.3

1.4

13.42

12.62

umol/l

0.54

124

683

Malignant neoplasm

465

1952

1.40

9.99

1.4

11.90

12.39

umol/l

0.82

450

1844

6-mercaptopurine

3.53

9.91

1.6

1.5

10.65

10.40

umol/l

0.11

Infections of the skin and subcutaneous tissue

341

2313

1.45

9.89

1.4

13.54

12.21

umol/l

2.56

323

2185

Other viral diseases, not elsewhere classified, including avohilmo

171

1004

1.70

9.82

1.3

1.5

12.39

11.45

umol/l

0.85

163

951

Disorders of eyelid, lacrimal system and orbit

461

2441

1.39

9.82

1.4

12.47

12.55

umol/l

0.08

435

2305

Voice disturbances

148

843

1.76

9.71

1.3

1.5

12.45

12.57

umol/l

0.08

139

788

Use of hypnotics and sedatives

576

2453

1.34

9.69

1.4

12.49

12.47

umol/l

0.03

539

2329

Ischaemic heart disease, wide definition

380

1634

1.43

9.55

1.6

1.4

15.06

12.88

umol/l

5.69

353

1547

Covid-19 suspected case

138

775

1.79

9.52

1.4

12.16

11.34

umol/l

0.67

133

731

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

335

2013

1.45

9.48

1.4

14.06

12.99

umol/l

1.52

314

1896

Liquid cancers, including Hilmo

177

935

1.67

9.47

1.4

1.5

13.99

13.63

umol/l

0.26

171

872

Atherosclerosis, excluding cerebral and coronary sclerosis

180

847

1.67

9.45

1.3

1.4

16.07

14.31

umol/l

1.67

173

789

Urinary track infection

321

1082

1.49

9.39

1.5

1.3

11.15

10.66

umol/l

0.66

302

1032

Solid cancers, including Hilmo

463

1954

1.38

9.38

1.4

11.91

12.45

umol/l

0.91

448

1846

Myocardial infarction, strict

209

919

1.61

9.35

1.5

1.4

16.50

13.51

umol/l

4.50

188

855

Non-rheumatic valve diseases

222

999

1.59

9.35

1.4

14.83

12.65

umol/l

3.71

216

937

Myalgia

143

817

1.76

9.31

1.5

11.35

12.18

umol/l

0.76

137

766

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

436

2.06

9.28

1.5

16.18

13.82

umol/l

1.22

409

Abnormal involuntary movements

416

2.08

9.28

1.5

1.4

14.02

12.10

umol/l

1.68

388

Asthma-related infections

323

2176

1.45

9.28

1.3

1.4

13.02

12.30

umol/l

0.95

312

2050

Asthma, hospital admission 2, infections

323

2176

1.45

9.28

1.3

1.4

13.02

12.30

umol/l

0.95

312

2050

Other viral diseases, including avohilmo

230

1469

1.56

9.27

1.3

1.4

11.74

11.54

umol/l

0.15

220

1399

Other disorders of lacrimal gland

197

1229

1.61

9.19

1.4

11.55

12.31

umol/l

0.89

188

1156

Diagnoses used for exclusion with ILD

135

762

1.78

9.16

1.4

1.5

14.90

13.16

umol/l

1.48

129

715

Diseases of the musculoskeletal system and connective tissue

315

1065

1.49

9.16

1.5

1.4

11.89

11.80

umol/l

0.07

298

997

Bronchitis

586

2654

1.33

9.12

1.3

1.4

12.84

12.24

umol/l

1.29

561

2497

Dermatitis and eczema

606

2723

1.32

9.08

1.3

1.4

12.02

12.46

umol/l

0.90

565

2581

Symptoms and signs involving the urinary system

387

2080

1.41

9.04

1.3

1.4

13.83

12.77

umol/l

1.94

365

1965

Concussion

241

1216

1.54

8.99

1.5

1.4

11.72

11.97

umol/l

0.27

230

1158

Sleep disorders (combined)

588

2318

1.33

8.97

1.4

12.16

12.55

umol/l

0.62

553

2192

External causes of morbidity and mortality

348

1205

1.45

8.95

1.4

12.22

11.65

umol/l

0.75

326

1145

Other aneurysm

112

3.16

8.92

1.4

1.5

11.83

13.93

umol/l

1.33

101

Other nutritional deficiencies

372

2425

1.40

8.87

1.3

1.4

12.90

12.03

umol/l

1.46

341

2299

Persons encountering health services in other circumstances

212

1343

1.57

8.85

1.3

1.4

12.61

12.05

umol/l

0.54

200

1270

Other acute lower respiratory infections

290

1892

1.46

8.73

1.4

13.04

12.46

umol/l

0.78

281

1783

Secondary hypertension

154

2.77

8.73

1.3

1.6

19.85

11.83

umol/l

3.97

143

Convulsions, not elsewhere classified

126

699

1.79

8.70

1.3

1.5

13.72

12.07

umol/l

1.44

115

660

Chronic pancreatitis

347

2.15

8.69

1.4

13.29

13.46

umol/l

0.07

321

Any event in cancer register

495

2145

1.35

8.67

1.3

1.4

11.90

12.26

umol/l

0.56

479

2025

Disorders of lens

335

1447

1.44

8.64

1.5

1.4

14.24

12.96

umol/l

2.13

313

1371

Fracture of rib(s), sternum and thoracic spine

160

966

1.66

8.55

1.4

14.16

13.48

umol/l

0.55

148

907

Obesity related asthma

192

1213

1.59

8.54

1.3

1.4

13.51

12.43

umol/l

1.12

182

1141

Cough

206

1232

1.56

8.51

1.4

11.66

12.32

umol/l

0.87

195

1162

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

307

2047

1.44

8.51

1.4

10.89

11.78

umol/l

1.47

289

1940

250

1669

1.49

8.32

1.3

1.4

12.75

11.91

umol/l

0.95

242

1577

Panic disorder

496

1.93

8.32

1.3

1.5

12.19

11.31

umol/l

0.54

475

Other complications of surgical and medical care, not elsewhere classified

276

2.26

8.29

1.4

1.5

13.52

11.54

umol/l

0.99

259

Post-traumatic stress disorder

258

2.30

8.23

1.2

1.5

10.68

10.44

umol/l

0.14

246

Phobic anxiety disorders

456

1.96

8.18

1.5

11.89

11.40

umol/l

0.21

439

Other obstetric conditions, not elsewhere classified

189

747

1.60

8.09

1.4

1.3

9.44

9.87

umol/l

0.54

174

719

Allergic conjunctivitis

318

2167

1.41

8.04

1.4

10.92

11.79

umol/l

1.49

300

2055

Type 2 diabetes, wide definition

391

1789

1.38

8.04

1.4

14.82

12.35

umol/l

6.97

364

1697

Disorders of lacrimal system

228

1493

1.51

8.01

1.4

11.41

12.47

umol/l

1.69

216

1403

Persons with potential health hazards related to communicable diseases

223

1465

1.51

8.01

1.3

1.4

11.25

11.28

umol/l

0.02

208

1399

Congenital malformations of cardiac chambers and connections

13.69

7.98

1.6

1.8

17.31

10.30

umol/l

—

Hypo-osmolality and hyponatraemia

437

1.96

7.96

1.4

1.5

15.02

13.46

umol/l

0.92

407

Other and unspecified immunodeficiencies with predominantly antibody defects

7.98

7.94

1.5

1.9

11.24

11.11

umol/l

0.03

Polyuria

114

641

1.79

7.91

1.4

13.80

13.32

umol/l

0.30

108

596

Viral infections characterized by skin and mucous membrane lesions

232

1555

1.50

7.89

1.3

1.5

13.45

12.35

umol/l

1.41

218

1471

Injuries to the thorax

234

1572

1.49

7.87

1.5

1.4

13.40

13.11

umol/l

0.25

219

1484

Gastro-oesophageal reflux disease

343

2079

1.39

7.84

1.3

1.4

12.78

12.39

umol/l

0.48

326

1967

Chronic hepatitis NAS

7.15

7.84

1.8

1.9

11.50

11.75

umol/l

0.08

Asthma-related pneumonia

183

1165

1.57

7.80

1.3

1.5

14.22

12.90

umol/l

1.51

178

1089

Mycoses

153

938

1.64

7.75

1.5

1.4

13.00

12.55

umol/l

0.32

145

882

Asthma-related pneumonia or sepsis

183

1167

1.57

7.74

1.3

1.5

14.22

12.90

umol/l

1.50

178

1091

Asthma, hospital admissions 3, pneumonia

183

1167

1.57

7.74

1.3

1.5

14.22

12.90

umol/l

1.50

178

1091

Diverticular disease of intestine

334

1480

1.41

7.70

1.4

13.84

13.03

umol/l

1.13

316

1394

Injuries to the hip and thigh

235

1420

1.49

7.69

1.4

15.63

12.93

umol/l

3.74

222

1335

Injury, poisoning and certain other consequences of external causes

291

1007

1.45

7.61

1.4

11.89

11.71

umol/l

0.17

272

958

Sleep apnoea

494

2363

1.32

7.60

1.4

12.40

12.57

umol/l

0.21

463

2235

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

183

729

1.59

7.56

1.4

1.3

9.45

9.84

umol/l

0.48

169

701

Systemic disorders of connective tissue in diseases classified elsewhere

14.39

7.53

1.3

1.4

13.48

14.33

umol/l

—

Retinal detachments and breaks

169

1070

1.58

7.51

1.5

1.4

12.51

13.57

umol/l

1.17

159

1001

Cutaneous abscess, furuncle and carbuncle

151

931

1.63

7.50

1.5

1.4

13.22

12.27

umol/l

0.84

144

882

Superficial injury of head

130

770

1.69

7.50

1.5

1.4

13.40

12.59

umol/l

0.64

123

729

Asthma (diagnoses ohter than nonallergic)

460

2820

1.32

7.36

1.3

1.4

12.56

12.31

umol/l

0.29

442

2657

Senile cataract

291

1242

1.43

7.26

1.4

14.73

13.15

umol/l

2.60

271

1176

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

116

2.87

7.22

1.6

11.59

15.43

umol/l

2.98

102

Other diseases of pericardium

100

3.03

7.20

1.3

1.5

16.03

12.98

umol/l

1.19

Sequelae of external causes of morbidity and mortality

133

803

1.66

7.20

1.5

1.4

13.77

12.71

umol/l

0.75

127

749

Hypokalaemia

320

2.07

7.18

1.2

1.5

15.47

13.10

umol/l

0.87

292

Bacterial pneumonia, not elsewhere classified

180

1022

1.55

7.17

1.3

1.4

14.93

13.02

umol/l

2.43

170

967

Other specific joint derangements/joint disorders

414

1926

1.34

7.16

1.4

12.09

11.83

umol/l

0.33

392

1822

Biological medication for rheuma

112

647

1.74

7.15

1.4

1.5

11.91

11.65

umol/l

0.17

107

618

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

483

2884

1.31

7.14

1.3

1.4

12.37

12.31

umol/l

0.07

460

2725

Volume depletion

230

2.27

7.11

1.3

1.5

16.26

14.44

umol/l

0.62

206

Obesity, other/unspecified

196

1300

1.51

7.10

1.2

1.4

12.90

11.45

umol/l

2.03

182

1233

Faecal incontinence

232

2.26

6.98

1.4

13.44

12.76

umol/l

0.22

212

Low back pain

414

2099

1.33

6.98

1.4

13.57

12.18

umol/l

2.62

396

1984

Fracture of femur

116

612

1.71

6.93

1.4

17.68

13.53

umol/l

3.15

109

567

Disorders of adult personality and behaviour

167

1076

1.56

6.93

1.3

1.4

12.03

11.46

umol/l

0.43

150

1027

Social phobias

272

2.15

6.89

1.7

1.5

10.76

11.14

umol/l

0.23

264

Solid cancers

430

1901

1.33

6.89

1.4

11.82

12.49

umol/l

1.24

415

1793

Disorders of ocular muscles, binocular movement, accommodation and refraction

262

1833

1.42

6.88

1.4

11.38

11.84

umol/l

0.52

243

1740

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

154

2.55

6.85

1.6

12.19

15.03

umol/l

1.83

140

Conjunctivitis (acute, non atopic), including avohilmo

528

2478

1.29

6.81

1.3

1.4

12.15

12.53

umol/l

0.67

503

2337

Myocardial infarction, with ST-elevation

417

1.90

6.77

1.3

1.5

17.39

14.60

umol/l

1.59

386

Acute upper respiratory infections of multiple and unspecified sites

411

2268

1.32

6.69

1.3

1.4

12.42

12.06

umol/l

0.52

395

2141

Non-selective monoamine reuptake inhibitors

168

1047

1.54

6.69

1.4

13.34

13.04

umol/l

0.18

157

992

Soft tissue disorders related to use, overuse and pressure

140

874

1.61

6.67

1.4

1.5

12.96

12.94

umol/l

0.01

133

819

Other symptoms and signs involving the nervous and musculoskeletal systems

213

1457

1.47

6.65

1.3

1.4

12.72

12.12

umol/l

0.56

195

1379

Finngen Rheumatological endpoints

511

2250

1.29

6.64

1.4

12.98

11.92

umol/l

2.44

490

2127

Personality disorders

156

1001

1.56

6.62

1.3

1.5

12.15

11.47

umol/l

0.50

140

955

Bacterial pneumoniae

188

1098

1.51

6.61

1.3

1.4

14.75

12.86

umol/l

2.51

177

1033

Other viral diseases

169

1100

1.54

6.61

1.3

1.4

11.84

11.65

umol/l

0.12

163

1042

Irregular menses

257

1361

1.42

6.55

1.3

10.80

10.65

umol/l

0.14

245

1295

Sleep apnoea, including avohilmo

517

2437

1.28

6.54

1.5

1.4

12.14

12.53

umol/l

0.66

481

2308

Zoster [herpes zoster]

502

1.80

6.51

1.3

1.5

15.29

13.13

umol/l

1.49

467

Mycoses, including avohilmo

486

2880

1.29

6.46

1.4

12.38

12.31

umol/l

0.07

460

2724

Disturbance of activity and attention

491

1.80

6.45

1.3

1.4

9.62

10.45

umol/l

0.71

467

Invasive ventilation

202

2.30

6.44

1.3

1.5

16.04

12.88

umol/l

1.08

186

Acute myeloid leukaemia and myelodysplastic syndromes

4.10

6.37

1.1

1.9

15.77

14.73

umol/l

0.16

Livedoid vasculitis

19.05

6.34

1.3

1.2

16.22

13.00

umol/l

—

Endometriosis

163

609

1.56

6.28

1.4

11.46

11.58

umol/l

0.07

155

578

Diabetes mellitus

533

2421

1.27

6.26

1.4

13.90

11.68

umol/l

7.94

496

2307

Behavioural syndromes associated with physiological disturbances and physical factors

499

2643

1.28

6.25

1.4

11.20

12.51

umol/l

4.12

471

2498

Cervicalgia

113

682

1.66

6.20

1.4

1.5

12.14

12.16

umol/l

0.01

105

635

Acute upper respiratory infections

533

2518

1.27

6.19

1.4

12.38

12.35

umol/l

0.03

505

2372

Migraine without aura and triptan purchases

103

607

1.71

6.18

1.4

10.41

10.33

umol/l

0.03

576

Fracture of lumbar spine and pelvis

104

613

1.70

6.17

1.5

14.08

13.19

umol/l

0.67

572

Diabetes, varying definitions

530

2422

1.27

6.13

1.4

13.95

11.67

umol/l

8.20

493

2308

Sulfasalazine

139

885

1.58

6.13

1.4

11.56

12.27

umol/l

0.92

134

831

Unspecific neurodegenerative disorder

157

697

1.55

6.01

1.6

1.4

14.77

15.05

umol/l

0.16

145

644

L02BA Anti-estrogens

471

1.79

6.01

1.4

1.5

10.92

11.49

umol/l

0.35

445

Cellulitis

122

760

1.61

5.92

1.4

13.60

12.72

umol/l

0.66

114

719

Diplopia

394

1.86

5.92

1.3

1.5

11.91

12.94

umol/l

0.72

369

Chronic rhinitis, nasopharyngitis and pharyngitis

173

1165

1.49

5.91

1.4

1.5

11.78

12.11

umol/l

0.31

168

1100

Idiopathic thrombocytopenic purpura

3.23

5.89

1.4

1.7

12.36

13.42

umol/l

0.39

Unspecified haematuria

189

1050

1.47

5.87

1.4

14.83

13.64

umol/l

1.35

176

984

Thyrotoxicosis with diffuse goitre

411

1.83

5.80

1.3

1.4

11.88

11.73

umol/l

0.05

395

Dermatitis

316

2319

1.33

5.76

1.3

1.4

12.56

12.53

umol/l

0.02

295

2197

Benign neoplasm: Transverse colon

300

1.98

5.72

1.6

1.5

14.20

13.62

umol/l

0.17

279

Type 2 diabetes

499

2283

1.27

5.69

1.4

13.97

11.78

umol/l

7.38

464

2174

Nontraumatic intracranial haemmorrhage

457

1.78

5.68

1.3

1.5

13.30

13.97

umol/l

0.35

423

Angina pectoris

233

1099

1.41

5.62

1.5

1.4

15.48

13.14

umol/l

3.95

217

1028

Other sleep disorders

332

1.91

5.52

1.3

1.5

12.02

12.58

umol/l

0.26

310

Enlarged lymph nodes

447

1.77

5.51

1.3

1.4

12.33

12.20

umol/l

0.07

421

Candidiasis, including avohilmo

157

1053

1.50

5.51

1.3

1.4

12.00

11.79

umol/l

0.12

145

992

Other or unspecified immunodeficiency

16.80

5.47

1.0

2.4

12.94

11.20

umol/l

—

Substance abuse, excluding more controls

261

1600

1.37

5.43

1.3

1.4

14.13

12.60

umol/l

1.92

226

1526

Intestinal adhesions without obstruction

205

2.16

5.40

1.3

1.4

14.98

12.33

umol/l

1.59

188

Aortic aneurysm

101

603

1.65

5.39

1.4

14.15

14.45

umol/l

0.13

557

Other cataract

201

1047

1.43

5.38

1.4

14.14

13.14

umol/l

0.92

182

987

Specific personality disorders

133

867

1.54

5.36

1.3

1.5

12.19

11.43

umol/l

0.49

119

829

Injuries to the abdomen, lower back, lumbar spine and pelvis

198

1376

1.42

5.35

1.4

13.64

12.56

umol/l

1.19

189

1294

Inflammatory diseases of female pelvic organs

307

1577

1.33

5.34

1.4

1.3

10.61

11.25

umol/l

0.92

293

1496

Other inflammation of eyelid, including avohilmo

237

1728

1.37

5.28

1.4

11.37

11.67

umol/l

0.32

223

1641

Cholecystitis

359

1.85

5.26

1.6

1.4

14.09

13.54

umol/l

0.29

330

Injuries to the ankle and foot

389

2594

1.28

5.24

1.4

11.85

11.98

umol/l

0.14

370

2460

Hyperkinetic disorders

545

1.67

5.24

1.3

1.4

9.69

10.42

umol/l

0.62

519

Asthma, hospital admissions , main diagnosis only

415

2842

1.27

5.24

1.3

1.4

12.46

12.28

umol/l

0.19

400

2679

Dipeptidyl peptidase 4 (DPP-4) inhibitors

243

1389

1.37

5.23

1.3

1.4

15.46

13.36

umol/l

3.77

225

1319

Malignant neoplasm of digestive organs, including Hilmo

187

956

1.44

5.23

1.4

1.5

12.66

13.77

umol/l

1.26

174

891

Complex cardiac defects

7.65

5.21

1.2

1.6

18.64

10.81

umol/l

0.96

Other and unspecified dermatitis

263

1954

1.35

5.20

1.3

1.4

12.49

12.43

umol/l

0.05

247

1854

Personal history of other diseases and conditions

359

1.84

5.19

1.5

1.4

11.92

10.00

umol/l

1.18

341

Chronic lower respiratory diseases

625

2693

1.22

5.18

1.3

1.4

13.16

12.09

umol/l

2.65

593

2547

Genitourinary diseases

291

1084

1.35

5.16

1.4

13.17

12.25

umol/l

1.17

272

1032

Other disorders of kidney and ureter

384

1.81

5.13

1.3

1.5

17.76

13.41

umol/l

2.57

356

Caries of enamel

504

2650

1.25

5.13

1.4

11.61

12.35

umol/l

1.86

473

2507

Defects in the complement system

10.30

5.06

1.6

11.30

10.56

umol/l

—

Benign neoplasm: Colon, unspecified

113

720

1.57

5.06

1.4

13.91

13.75

umol/l

0.08

108

670

Autonomic disorders

3.21

5.06

1.7

1.6

9.61

12.11

umol/l

1.26

Insulin, intermediate and long-acting

258

1851

1.35

5.05

1.4

14.38

12.91

umol/l

2.21

236

1748

Hernia

466

2473

1.25

5.04

1.4

13.49

12.35

umol/l

2.79

442

2335

Acute tubulo-interstitial nephritis

287

1826

1.33

5.03

1.5

1.4

14.37

11.91

umol/l

5.32

271

1712

Nerve, nerve root and plexus disorders

532

2588

1.24

4.98

1.3

1.4

13.11

12.39

umol/l

1.38

499

2455

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

107

655

1.59

4.96

1.3

1.5

13.07

13.93

umol/l

0.55

102

608

Use of anticholinesterases

127

639

1.54

4.92

1.7

1.4

14.86

15.24

umol/l

0.21

115

589

N06DA Anticholinesterases

127

639

1.54

4.92

1.7

1.4

14.86

15.24

umol/l

0.21

115

589

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

214

1535

1.38

4.90

1.3

1.4

11.60

11.32

umol/l

0.26

207

1462

Nonalcoholic fatty liver disease

332

1.85

4.89

1.6

1.5

14.39

12.05

umol/l

1.19

312

Status post-ami

102

480

1.62

4.89

1.5

1.4

17.35

14.23

umol/l

3.02

439

Malignant neoplasm of digestive organs

168

889

1.45

4.89

1.4

1.5

12.55

13.98

umol/l

1.86

158

829

Erosion of teeth , including avohilmo

151

1033

1.47

4.87

1.4

11.04

11.59

umol/l

0.65

141

977

Obesity and other hyperalimentation

327

2378

1.29

4.84

1.3

1.4

13.02

11.93

umol/l

1.93

306

2254

Other and unspecified disorders of binocular movement

9.32

4.83

1.1

1.7

11.72

11.30

umol/l

—

Heartburn

312

1.87

4.82

1.4

1.3

12.83

12.24

umol/l

0.23

290

Congenital malformations of pulmonary and tricuspid valves

9.25

4.82

1.2

1.9

12.22

10.92

umol/l

—

Other (seronegative) rheumatoid arthritis, wide

527

1.66

4.81

1.4

1.5

12.77

12.85

umol/l

0.03

495

Mental disorders, not otherwise specified

285

1.91

4.77

1.7

1.6

11.61

11.25

umol/l

0.16

271

Bacterial pneumonia (organism specified)

198

1291

1.39

4.74

1.3

1.4

14.82

13.12

umol/l

2.19

186

1211

Multiple myeloma, including Hilmo

2.63

4.73

1.3

1.7

16.44

14.11

umol/l

0.60

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

108

2.52

4.71

1.6

12.81

15.55

umol/l

1.14

Gastroduodenal ulcer

109

699

1.56

4.70

1.4

13.55

14.11

umol/l

0.35

103

650

Obesity

324

2369

1.29

4.67

1.3

1.4

13.06

11.91

umol/l

2.08

304

2245

Restless leg syndrome

434

1.71

4.63

1.4

1.5

10.90

12.29

umol/l

1.25

404

Gingivitis and periodontal diseases

496

2072

1.24

4.63

1.4

12.64

12.17

umol/l

0.79

462

1960

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

3.38

4.62

1.7

1.9

10.97

15.47

umol/l

2.01

Acute sinusitis

279

1934

1.31

4.61

1.4

11.73

11.76

umol/l

0.02

263

1836

Melanocytic naevi

161

1129

1.43

4.58

1.3

1.5

11.26

12.04

umol/l

0.86

154

1063

Lymphangioma, anys site

6.85

4.50

1.1

1.6

9.47

10.43

umol/l

—

Other and unspecified disorders of vitreous body

188

1328

1.39

4.49

1.4

11.85

13.26

umol/l

2.24

181

1247

Insulin, combination of fast acting with intermediate-acting or long-acting

287

2001

1.30

4.47

1.4

14.42

12.81

umol/l

2.88

264

1894

Diseases of the ear and mastoid process

594

2463

1.21

4.44

1.4

11.61

12.40

umol/l

2.11

554

2338

Exposure to other specified factors

415

2865

1.24

4.44

1.3

1.4

11.88

12.25

umol/l

0.58

392

2711

Presence of other functional implants

241

1234

1.34

4.39

1.3

1.4

13.06

13.29

umol/l

0.19

226

1154

Fall on and from stairs and steps

128

867

1.48

4.38

1.3

1.4

13.67

12.69

umol/l

0.74

122

815

Migraine with aura and triptan purchases

573

1.59

4.35

1.4

10.51

10.48

umol/l

0.02

542

Monoamine oxidase A inhibitors

316

1.81

4.35

1.3

1.5

12.45

13.12

umol/l

0.25

300

Migraine, single triptan purchase ok & required. ICD-code if available is included

404

2194

1.25

4.31

1.4

10.59

12.06

umol/l

4.76

382

2087

Triptan medication for migraine, single purchase ok

404

2194

1.25

4.31

1.4

10.59

12.06

umol/l

4.76

382

2087

Type 2 diabetes, definitions combined

462

2181

1.23

4.31

1.4

14.22

11.85

umol/l

8.33

431

2076

Sleep disorders

463

2596

1.23

4.30

1.4

11.29

12.51

umol/l

3.34

437

2455

Infections with a predominantly sexual mode of transmission

164

1166

1.41

4.29

1.4

11.22

10.97

umol/l

0.18

154

1108

Insulin medication

287

1840

1.30

4.28

1.4

14.42

12.49

umol/l

3.89

264

1756

Uterine polyps

125

486

1.51

4.28

1.5

1.4

11.14

11.96

umol/l

0.69

120

461

Atrophic disorders of skin

483

1.64

4.26

1.5

9.74

11.85

umol/l

3.67

454

Disorders of vitreous body and globe

229

1628

1.33

4.24

1.4

12.34

13.20

umol/l

1.04

218

1523

Other and unspecified disorders of white blood cells

108

2.43

4.23

1.1

1.6

14.30

13.66

umol/l

0.13

101

Other/unspecified dorsalgia

181

1298

1.38

4.23

1.3

1.4

13.38

12.10

umol/l

1.37

171

1223

Disorders of skin appendages

256

1949

1.31

4.21

1.4

12.31

11.80

umol/l

0.61

239

1853

Disorders of choroid and retina

369

2057

1.26

4.21

1.4

13.25

13.07

umol/l

0.18

345

1940

Vasculitis limited to skin, not elsewhere classified

2.94

4.18

1.2

1.5

14.82

13.71

umol/l

0.28

Asthma, including avohilmo

598

2748

1.20

4.18

1.3

1.4

12.72

12.26

umol/l

0.72

570

2596

Conjunctivitis (acute, non atopic)

144

1004

1.43

4.16

1.3

1.5

12.04

12.05

umol/l

0.01

138

951

Right ventricular outflow tract obstruction

6.04

4.16

1.2

1.7

17.20

10.42

umol/l

—

Disorders of vitreous body

223

1595

1.33

4.14

1.4

12.36

13.20

umol/l

0.99

214

1491

Malignant neoplasm of other and unspecified parts of biliary tract

4.07

4.12

1.6

1.9

10.91

15.51

umol/l

1.74

Spondylosis

249

1483

1.31

4.10

1.3

1.4

13.92

12.95

umol/l

1.16

238

1393

Medicines for HER+ breast cancer

158

1050

1.40

4.08

1.3

1.4

11.78

11.95

umol/l

0.11

152

986

Schizophrenia or delusion, excluding more controls

140

967

1.43

4.07

1.2

1.4

13.10

12.28

umol/l

0.44

113

927

Multiple myeloma and malignant plasma cell neoplasms

104

2.42

4.06

1.3

1.6

16.44

15.22

umol/l

0.26

Open wound of head

260

1882

1.30

4.05

1.5

1.4

14.67

12.79

umol/l

2.79

245

1783

Lung transplant status

5.72

4.01

1.3

1.8

14.20

10.88

umol/l

—

Lung transplantation

5.72

4.01

1.3

1.8

14.20

10.88

umol/l

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.69

4.00

1.4

2.1

9.52

10.78

umol/l

—

Vitamin deficiency, wide

143

2.19

3.99

1.4

1.5

17.59

12.45

umol/l

1.72

133

Vitamin deficiency

143

2.19

3.99

1.4

1.5

17.59

12.45

umol/l

1.72

133

Dorsalgia

496

2164

1.22

3.99

1.4

12.57

12.16

umol/l

0.62

469

2043

Type 2 diabetes, strict (exclude DM1)

461

2197

1.22

3.97

1.4

14.24

11.85

umol/l

8.39

430

2090

Other diseases of pleura

183

1167

1.36

3.96

1.5

1.4

14.36

14.02

umol/l

0.21

175

1091

Fissure and fistula of anal and rectal regions

112

756

1.49

3.95

1.5

1.4

12.60

12.63

umol/l

0.02

102

712

Temporomandibular joint disorders, including avohilmo

229

1694

1.31

3.85

1.4

10.51

11.38

umol/l

1.52

218

1611

Ovarian cyst

155

629

1.41

3.85

1.4

10.97

11.53

umol/l

0.46

141

598

Retention of urine

138

784

1.43

3.83

1.3

1.4

14.41

13.79

umol/l

0.42

127

730

Fracture of skull and facial bones

107

721

1.49

3.82

1.5

12.97

12.75

umol/l

0.13

100

686

Thyrotoxicosis factitia

12.52

3.80

2.3

1.2

7.10

10.20

umol/l

—

Congenital stenosis of pulmonary valve

8.95

3.79

1.1

1.6

14.86

10.38

umol/l

—

Noninflammatory disorders of female genital tract

182

665

1.38

3.79

1.6

1.4

10.43

11.41

umol/l

1.07

169

634

Other spirochaetal diseases, including avohilmo

165

1205

1.37

3.78

1.4

10.53

12.55

umol/l

5.78

155

1136

Other dorsopathies, not elsewhere classified

504

2171

1.21

3.78

1.4

12.46

12.16

umol/l

0.45

479

2049

Hepatocellular carcinoma, including Hilmo

2.75

3.76

1.4

1.8

13.66

15.08

umol/l

0.32

Hypoparathyroidism

2.59

3.72

1.7

1.6

11.91

12.36

umol/l

0.15

All dysplastic lesions of the vulva

115

2.28

3.72

1.2

1.4

15.55

10.46

umol/l

1.62

108

Other specified/unspecified systemic involvement of connective tissue

161

2.06

3.71

1.1

1.5

12.80

11.87

umol/l

0.36

150

Diseases of inner ear

237

1751

1.30

3.68

1.4

13.08

12.92

umol/l

0.11

222

1650

Lower back pain or/and sciatica

533

2778

1.19

3.67

1.4

13.26

12.25

umol/l

2.08

507

2626

Haemorrhoids and perianal venous thrombosis

142

1010

1.40

3.66

1.5

1.4

12.95

12.92

umol/l

0.02

135

947

Disorders of vestibular function (Vertigo)

204

1506

1.32

3.65

1.4

13.10

12.88

umol/l

0.14

190

1415

Rheumatism, unspecified

357

1.69

3.65

1.3

1.5

11.75

11.97

umol/l

0.09

333

Disorders of sclera, cornea, iris and ciliary body

266

2092

1.27

3.62

1.4

12.71

12.39

umol/l

0.31

250

1978

Disorders of breast

228

1545

1.30

3.60

1.5

1.3

10.23

11.31

umol/l

2.20

216

1465

Infections with a predominantly sexual mode of transmission, including avohilmo

211

1473

1.31

3.58

1.3

1.4

11.21

11.06

umol/l

0.11

197

1407

Spondylopathies

363

1737

1.24

3.57

1.4

13.46

12.60

umol/l

1.39

347

1640

Malignant neoplasm of liver and intrahepatic bile ducts

2.67

3.57

1.8

1.7

11.83

15.19

umol/l

1.31

Scoliosis

263

1.80

3.55

1.4

1.5

12.37

11.31

umol/l

0.44

244

Exclusions for E4_PCOS_CONSORTIUM

354

1788

1.24

3.52

1.4

11.45

11.51

umol/l

0.06

329

1706

Marfan's syndrome

10.26

3.52

1.2

1.8

10.32

12.33

umol/l

—

Type 2 diabetes, definitions combined, including avohilmo

458

2201

1.20

3.46

1.4

14.16

11.86

umol/l

7.73

427

2097

Other spirochaetal diseases

161

1191

1.36

3.45

1.4

10.49

12.54

umol/l

6.01

151

1122

Lyme disease, including avohilmo

159

1174

1.36

3.44

1.4

10.46

12.56

umol/l

6.24

149

1106

Lyme disease

159

1174

1.36

3.44

1.4

10.46

12.56

umol/l

6.24

149

1106

Other disorders of eyelid

181

1286

1.33

3.41

1.4

13.67

13.34

umol/l

0.25

170

1202

Diseases of the respiratory system

313

1253

1.25

3.39

1.5

1.4

12.48

11.79

umol/l

0.90

294

1183

Rheumatoid arthritis, including avohilmo

164

1220

1.35

3.39

1.3

1.4

12.03

12.59

umol/l

0.50

155

1150

Arteriovenous malformation of peripheral vessels

7.20

3.39

1.4

1.7

8.71

11.40

umol/l

—

Other hereditary haemolytic anaemias

7.17

3.38

2.6

1.9

11.86

10.50

umol/l

—

Chronic sinusitis

204

1564

1.30

3.38

1.3

1.4

12.14

12.35

umol/l

0.14

189

1484

Spirochaetal infections, other/unspecified, including avohilmo

160

1187

1.35

3.37

1.4

10.55

12.56

umol/l

5.58

150

1119

Unspecified fall

237

1821

1.28

3.37

1.4

13.69

12.53

umol/l

1.41

221

1719

Myocardial infarction, without ST-elevation

149

985

1.37

3.35

1.5

1.4

16.72

14.38

umol/l

2.19

136

917

Abnormal findings on diagnostic imaging of lung

197

1429

1.31

3.31

1.4

14.67

13.59

umol/l

1.10

183

1339

Spinal stenosis

207

1172

1.30

3.28

1.4

15.05

13.41

umol/l

1.95

196

1093

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.80

3.26

1.3

1.7

16.32

15.16

umol/l

0.17

Multiple myeloma

2.80

3.26

1.3

1.7

16.32

15.16

umol/l

0.17

Arthropathies

466

1969

1.20

3.26

1.4

12.27

11.90

umol/l

0.52

443

1861

Other diseases of arteries and capillaries

249

1.78

3.23

1.3

1.5

12.10

12.55

umol/l

0.16

230

Injuries to the elbow and forearm

349

2454

1.22

3.23

1.4

12.75

12.26

umol/l

0.59

332

2315

Right side

6.56

3.21

1.3

2.4

12.71

14.28

umol/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

561

1.46

3.21

1.2

1.4

10.61

10.94

umol/l

0.18

536

Insulin, fast-acting

164

1232

1.33

3.19

1.4

13.72

12.57

umol/l

1.03

153

1165

Disorders resulting from impaired renal tubular function

2.33

3.18

1.3

1.6

24.67

13.67

umol/l

2.73

Thyroiditis

214

1.83

3.18

1.6

1.5

11.01

11.33

umol/l

0.11

199

Polyp of the female genital tract

126

507

1.41

3.17

1.6

1.4

10.89

11.91

umol/l

0.97

119

481

Chronic apical periodontitis

547

2612

1.17

3.16

1.3

1.4

13.23

12.18

umol/l

2.74

512

2467

Viral and other specified intestinal infections, including avohilmo

141

998

1.36

3.15

1.4

11.80

11.18

umol/l

0.56

135

942

Rheumatoid arthritis

140

909

1.37

3.15

1.3

1.4

12.04

12.51

umol/l

0.36

132

851

Polycystic ovarian syndrome, consortium definition

333

1556

1.23

3.13

1.4

1.3

10.87

11.15

umol/l

0.34

316

1478

Diseases of oral cavity, salivary glands and jaws

261

1064

1.27

3.12

1.4

13.42

12.80

umol/l

0.63

244

1008

Diseases of salivary glands

153

1143

1.34

3.11

1.2

1.4

13.45

12.21

umol/l

1.07

143

1080

Herpesviral [herpes simplex] infections, including avohilmo

128

930

1.38

3.11

1.4

1.5

11.05

11.29

umol/l

0.20

120

882

Injuries to the knee and lower leg

588

2727

1.17

3.09

1.3

1.4

12.48

12.31

umol/l

0.23

554

2580

Intracranial injury

270

2023

1.24

3.08

1.4

12.20

12.34

umol/l

0.15

254

1909

Infarction of spleen

5.13

3.07

1.3

2.0

12.10

12.57

umol/l

—

Dorsopathies

508

2182

1.18

3.05

1.4

12.19

12.13

umol/l

0.07

487

2060

Other diseases of upper respiratory tract

526

2333

1.18

3.03

1.3

1.4

12.10

12.69

umol/l

1.04

496

2205

Congenital malformations of aortic and mitral valves

126

2.08

3.03

1.3

1.6

12.73

12.86

umol/l

0.03

121

Calculus of kidney and ureter

129

943

1.37

3.03

1.4

15.05

13.47

umol/l

1.22

120

880

Triptan medication for migraine, min. 3 purchases

285

1723

1.24

3.00

1.4

9.97

11.27

umol/l

3.96

269

1642

Early onset COPD, excluding more controls

553

1.49

2.99

1.4

16.08

13.16

umol/l

1.85

523

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

100

2.21

2.98

1.1

1.7

11.31

10.59

umol/l

0.22

Malignant neoplasm of breast, HER2-negative, including Hilmo

182

891

1.31

2.98

1.3

1.4

11.73

11.51

umol/l

0.15

174

837

Malignant neoplasm of breast, including Hilmo

182

891

1.31

2.98

1.3

1.4

11.73

11.51

umol/l

0.15

174

837

Unstable angina pectoris

132

760

1.37

2.95

1.5

1.4

15.37

13.75

umol/l

1.42

120

702

Malignant neoplasm of colon, including Hilmo

465

1.52

2.93

1.5

13.94

14.44

umol/l

0.16

430

Hepatocellular carcinoma

2.85

2.92

1.5

1.9

12.85

15.56

umol/l

0.72

Glomerular disorders in diseases classified elsewhere

342

1.61

2.90

1.3

1.5

21.31

13.37

umol/l

4.40

315

Bipolar affective disorders

648

1.44

2.90

1.3

1.5

11.88

11.64

umol/l

0.15

620

Hypoplasia of dental enamel, prenatal , including avohilmo

6.85

2.89

1.0

1.7

9.50

8.33

umol/l

—

Scar conditions and fibrosis of skin

115

2.10

2.89

1.5

8.76

11.09

umol/l

1.77

107

Seborrhoeic keratosis

101

715

1.42

2.88

1.5

1.4

12.42

13.02

umol/l

0.40

670

Allergic colitis

2.61

2.87

1.7

1.8

10.19

9.68

umol/l

0.16

Other and unspecified effects of external causes

136

1012

1.35

2.87

1.3

1.4

11.20

11.80

umol/l

0.64

127

957

Transport accidents

214

1406

1.27

2.85

1.3

1.4

12.19

11.81

umol/l

0.40

207

1340

Other and unspecified myopathies

237

1.74

2.84

1.1

1.5

15.72

13.98

umol/l

0.52

219

Other specified/unspecified arthritis

126

929

1.36

2.83

1.4

12.89

12.29

umol/l

0.47

119

873

Dialysis

103

2.15

2.81

1.5

1.6

20.40

12.60

umol/l

2.63

Zoster [herpes zoster], including avohilmo

224

1724

1.26

2.80

1.3

1.4

13.36

12.79

umol/l

0.55

214

1621

Insulin, fast-acting or short human

165

1267

1.30

2.80

1.4

13.72

12.70

umol/l

0.89

154

1194

Eclampsia

8.69

2.78

1.0

1.7

11.38

11.67

umol/l

—

Acne, including avohilmo

119

703

1.37

2.77

1.3

1.4

10.53

10.63

umol/l

0.06

110

668

Tetralogy of Fallot, a congenital heart defect.

8.57

2.77

1.2

1.8

24.40

7.67

umol/l

—

Urolithiasis

135

1010

1.34

2.77

1.4

15.01

13.45

umol/l

1.27

126

945

Other congenital malformations of kidney

8.56

2.77

1.6

1.0

8.86

11.00

umol/l

—

Other disorders of eye and adnexa

474

1.50

2.76

1.6

1.5

11.94

11.72

umol/l

0.09

446

Dystonia

166

1.88

2.76

1.5

1.4

10.44

11.97

umol/l

0.71

156

Shoulder lesions

339

1684

1.21

2.75

1.4

12.53

12.80

umol/l

0.30

321

1586

Disorders of plasma-protein metabolism, not elsewhere classified

5.10

2.74

1.6

10.51

11.06

umol/l

—

Other symptoms and signs involving the circulatory and respiratory systems

188

1.82

2.74

1.7

1.5

12.95

12.24

umol/l

0.21

174

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

123

898

1.35

2.72

1.2

1.4

11.41

11.65

umol/l

0.12

105

864

Fitting and adjustment of other devices

125

814

1.35

2.72

1.3

1.4

13.25

13.39

umol/l

0.07

119

753

Atopic dermatitis

304

1997

1.21

2.71

1.4

11.15

11.65

umol/l

0.74

285

1896

Other abnormal immunological findings in serum

2.62

2.71

1.2

1.7

13.86

11.20

umol/l

0.65

Female infertility, cervical, vaginal, other or unspecified origin

116

539

1.38

2.69

1.6

1.4

10.23

11.35

umol/l

1.19

109

516

COPD (mode)

116

661

1.37

2.68

1.3

1.4

17.22

13.32

umol/l

3.53

106

620

Insomnia

443

2628

1.17

2.68

1.4

11.21

12.37

umol/l

3.00

419

2486

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

138

1030

1.33

2.66

1.4

10.25

10.81

umol/l

0.65

130

978

Other specified and unspecified personality disorders

304

1.62

2.64

1.2

1.5

12.67

11.34

umol/l

0.40

287

Malignant neoplasm of breast

176

880

1.29

2.64

1.3

1.4

11.59

11.53

umol/l

0.03

168

827

Dentofacial anomalies [including malocclusion]

354

2324

1.19

2.64

1.4

10.47

11.91

umol/l

5.70

334

2202

Non-Hodgkin lymphoma, all

2.22

2.64

1.1

1.7

16.36

16.00

umol/l

0.08

Left ventricular outflow tract obstruction, narrow definition

162

1.86

2.62

1.3

1.6

12.80

12.44

umol/l

0.11

153

Strabismus

122

905

1.35

2.62

1.4

11.68

11.92

umol/l

0.13

111

856

Tinnitus

107

781

1.37

2.60

1.5

12.28

12.82

umol/l

0.25

102

733

Lifestyle-related condition

3.65

2.58

1.3

1.8

16.74

11.80

umol/l

—

Myelodysplastic syndrome

3.65

2.58

1.1

1.9

13.64

17.43

umol/l

—

Malignant neoplasm of colon

377

1.54

2.57

1.4

1.5

13.70

14.18

umol/l

0.13

348

Acute posthaemorrhagic anaemia

2.37

2.56

1.3

1.5

14.20

14.16

umol/l

0.01

Colonic or urogenital fistula

119

886

1.35

2.55

1.5

12.72

12.78

umol/l

0.03

109

836

Malignant neoplasm of breast, HER2-negative

175

880

1.28

2.53

1.3

1.4

11.57

11.53

umol/l

0.02

167

827

Other and unspecified nonorganic psychotic disorders

692

1.39

2.52

1.2

1.5

12.88

11.56

umol/l

0.55

663

Lactose intolerance, other/unspecified

2.29

2.51

1.6

1.7

14.48

11.78

umol/l

0.41

Sacrococcygeal disorders, not elsewhere classified

2.18

2.51

1.5

1.3

12.90

10.95

umol/l

0.48

Female infertility

125

557

1.35

2.51

1.5

1.4

10.27

11.35

umol/l

1.19

116

531

Scarlet fever, including avohilmo

4.44

2.48

1.1

1.6

13.80

9.41

umol/l

—

Benign neoplasm: Sigmoid colon

544

1.44

2.47

1.3

1.5

13.63

umol/l

0.00

510

Other diseases of gallbladder

116

1.99

2.46

1.6

1.5

13.81

12.95

umol/l

0.32

108

Acute peritonitis

166

1.82

2.44

1.5

14.03

13.47

umol/l

0.14

155

Fracture of forearm

252

1858

1.22

2.44

1.4

12.62

12.26

umol/l

0.29

239

1751

Other disorders of bone

655

1.39

2.43

1.4

13.32

12.05

umol/l

0.75

618

Diseases of external ear

159

1243

1.28

2.42

1.3

1.4

12.51

12.64

umol/l

0.09

143

1174

Benign neoplasm: Rectum, anus and anal canal

564

1.42

2.40

1.4

1.5

13.68

13.74

umol/l

0.02

528

Disorders of refraction and accommodation

140

1074

1.30

2.39

1.4

11.49

11.63

umol/l

0.09

132

1020

Unspecified mental disorder

188

1502

1.25

2.39

1.4

12.90

11.92

umol/l

0.77

157

1432

Atrioventricular septal defect

6.41

2.39

1.0

1.4

9.80

9.75

umol/l

—

Ovarian dysfunction, other/unspecified

6.36

2.38

1.2

1.8

14.18

13.00

umol/l

—

Paraplegia, diplegia of upper limbs

2.44

2.38

1.6

15.16

12.32

umol/l

0.51

Pregnancy examination and test

320

1.46

2.38

1.4

9.88

10.06

umol/l

0.12

307

Fibrosis of liver

4.20

2.37

1.4

1.9

10.71

12.94

umol/l

—

Unequal limb length (acquired)

4.18

2.37

1.3

2.1

11.57

10.13

umol/l

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

213

1.70

2.35

1.3

1.5

11.13

11.37

umol/l

0.08

200

Excessive, frequent and irregular menstruation

160

664

1.29

2.33

1.5

1.4

10.13

11.42

umol/l

1.95

150

633

Epilepsy

128

975

1.31

2.32

1.3

1.4

12.48

12.71

umol/l

0.15

119

928

Other joint disorders

438

1965

1.16

2.32

1.4

11.73

11.89

umol/l

0.20

414

1857

Acute myeloid leukaemia, helper endpoint

3.25

2.31

1.1

2.1

17.12

15.44

umol/l

—

Acute myeloid leukaemia, including Hilmo

3.25

2.31

1.1

2.1

17.12

15.44

umol/l

—

Acute myeloid leukaemia

3.25

2.31

1.1

2.1

17.12

15.44

umol/l

—

Other disorders of adrenal gland

119

1.94

2.30

1.3

1.5

11.77

11.93

umol/l

0.04

113

Other and unspecified papulosquamous disorders

4.70

2.28

1.0

1.8

14.85

13.39

umol/l

—

Non-invasive ventilation

520

1.40

2.26

1.4

1.5

12.34

10.98

umol/l

1.15

502

Benign thyroid growths and nodules

123

872

1.31

2.25

1.3

1.4

11.09

12.91

umol/l

2.33

116

823

Nonsuppurative otitis media, including avohilmo

159

1084

1.27

2.24

1.4

11.22

11.48

umol/l

0.20

150

1025

Type 1 diabetes

114

862

1.32

2.23

1.4

13.19

11.65

umol/l

1.17

106

820

Surgical ablation of atrial fibrillation

5.67

2.22

1.4

2.1

21.62

12.56

umol/l

—

Adverse effects, not elsewhere classified

675

1.37

2.22

1.3

1.4

11.06

11.63

umol/l

0.44

638

Serous carcinoma of ovary, including Hilmo

2.21

1.3

1.8

10.02

12.06

umol/l

0.87

Toxic effects of substances chiefly nonmedicinal as to source

393

1.48

2.18

1.2

1.5

13.33

11.90

umol/l

0.70

368

Herpesviral [herpes simplex] infections

361

1.50

2.16

1.5

12.02

11.67

umol/l

0.17

342

Drug-induced neutropenia

211

1.67

2.16

1.4

1.5

13.53

12.23

umol/l

0.50

198

HSIL lesion of the vulva

2.65

2.15

1.3

1.6

11.53

11.23

umol/l

0.06

Type 1 diabetes, wide definition, subgroup 1

704

1.35

2.15

1.4

13.30

11.43

umol/l

1.29

668

Other retinal disorders

261

1655

1.20

2.13

1.4

13.62

13.26

umol/l

0.33

242

1552

Lactose intolerance

2.06

2.12

1.6

14.06

11.47

umol/l

0.42

Chorioretinal inflammation

2.15

2.09

1.5

1.6

15.32

12.51

umol/l

0.58

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

5.09

2.08

1.2

1.8

10.00

13.50

umol/l

—

Other arthritis (FG)

138

1084

1.28

2.08

1.4

13.17

12.25

umol/l

0.86

130

1018

Cyst of kidney

183

1.70

2.08

1.4

1.5

15.92

13.84

umol/l

0.58

168

Menorrhagia

136

588

1.29

2.07

1.5

1.4

9.99

11.65

umol/l

2.21

128

558

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

256

1.58

2.07

1.2

1.6

9.51

9.98

umol/l

0.39

241

Striking against or struck by other objects

165

1323

1.25

2.06

1.3

1.4

11.54

12.12

umol/l

0.68

152

1250

Keratitis

160

1281

1.25

2.06

1.4

13.12

12.33

umol/l

0.72

149

1216

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

4.08

2.05

1.2

1.8

11.17

12.93

umol/l

—

Melanoma in situ of lower limb, including hip

4.07

2.05

2.2

1.6

9.43

13.60

umol/l

—

Other diseases of hard tissues of teeth

246

1057

1.21

2.04

1.4

12.28

12.75

umol/l

0.45

229

1001

Lymphoid leukaemia

125

1.85

2.02

1.4

1.6

12.00

14.56

umol/l

1.21

118

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

433

2239

1.15

2.01

1.3

1.4

14.43

11.87

umol/l

8.54

399

2132

In situ neoplasms

160

1287

1.25

1.99

1.6

1.4

13.84

12.51

umol/l

1.39

153

1203

Social disorders starting during childhood or adolecense, excluding more controls

3.38

1.97

1.6

1.8

11.14

9.51

umol/l

—

Social disorders starting during childhood or adolescence

3.38

1.97

1.6

1.9

11.14

9.92

umol/l

—

Other arthrosis

236

1317

1.20

1.97

1.4

12.38

12.73

umol/l

0.35

221

1244

Benign paroxysmal vertigo

118

916

1.29

1.97

1.4

12.79

12.88

umol/l

0.04

109

863

Maternal care for other conditions predominantly related to pregnancy

103

765

1.32

1.96

1.3

9.31

9.94

umol/l

0.93

733

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

112

1.89

1.96

1.2

1.7

10.31

10.37

umol/l

0.02

104

Urticaria and erythema

169

1371

1.23

1.94

1.4

1.5

11.43

11.76

umol/l

0.24

158

1298

Otorrhagia

3.81

1.94

1.8

1.9

15.02

13.06

umol/l

—

Obesity due to excess calories

224

1871

1.20

1.93

1.3

1.4

13.58

11.68

umol/l

3.38

212

1774

Postprocedural disorders of digestive system, not elsewhere classified

2.01

1.90

1.1

1.6

12.40

12.96

umol/l

0.13

Other specified and unspecified disorders of conjunctiva

3.22

1.89

1.1

2.1

13.64

12.58

umol/l

—

Lumbar disc prolapse

295

1869

1.17

1.86

1.3

1.4

13.29

12.34

umol/l

1.20

279

1767

LSIL lesion of the vulva

2.04

1.86

1.2

1.4

17.71

10.20

umol/l

1.50

Spasmodic torticollis

2.04

1.85

1.3

1.5

10.62

11.32

umol/l

0.16

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

237

1925

1.19

1.85

1.4

11.87

12.67

umol/l

1.00

229

1822

Selective deficiency of immunoglobulin G [IgG] subclasses

3.59

1.85

2.3

2.1

9.12

10.88

umol/l

—

Collapsed vertebra, not elsewhere classified

3.58

1.84

2.2

1.7

13.28

14.32

umol/l

—

Rotator cuff syndrome

261

1522

1.18

1.84

1.5

1.4

12.52

13.14

umol/l

0.77

250

1429

Colorectal cancer

611

1.34

1.83

1.3

1.5

14.02

14.19

umol/l

0.06

565

Other and unspecified abdominal hernia

101

1.89

1.81

1.2

1.5

16.33

13.41

umol/l

0.77

Other strabismus

101

776

1.30

1.80

1.5

1.4

11.68

11.67

umol/l

0.00

738

Atopic dermatitis, strict definition with reimbursement

148

1149

1.24

1.79

1.5

1.4

10.96

11.19

umol/l

0.19

139

1100

Melanocytic naevi of upper limb, including shoulder

2.18

1.78

1.2

1.7

13.98

12.33

umol/l

0.30

Nail disorders

288

1.50

1.76

1.6

1.5

13.04

12.07

umol/l

0.46

270

Corneal scars and opacities

2.10

1.76

1.1

1.6

13.21

13.06

umol/l

0.03

Agoraphobia

1.91

1.75

1.7

1.5

13.33

10.00

umol/l

0.54

Other specified disorders of kidney and ureter

1.94

1.75

1.4

1.6

12.87

13.43

umol/l

0.12

Viral warts, including avohilmo

104

810

1.29

1.73

1.4

1.5

11.87

11.57

umol/l

0.19

765

Contact with and exposure to communicable diseases

149

1205

1.23

1.73

1.3

1.4

10.66

10.96

umol/l

0.29

137

1153

Nonsuppurative otitis media

113

770

1.27

1.73

1.5

11.46

11.45

umol/l

0.00

108

720

Dermatophytosis, including avohilmo

302

2560

1.16

1.73

1.4

12.32

12.40

umol/l

0.07

290

2411

Paracetamol or NSAID medication

307

1.35

1.72

1.6

1.5

12.57

12.77

umol/l

0.08

291

Disorders of muscles

306

1.47

1.72

1.4

1.5

12.69

12.39

umol/l

0.11

282

Isolated growth hormone deficiency

3.90

1.72

1.2

1.6

7.12

8.24

umol/l

—

Seropositive rheumatoid arthritis

737

1.30

1.71

1.3

1.4

11.87

12.44

umol/l

0.40

685

Cervical disc disorders

148

1204

1.23

1.71

1.4

12.64

12.88

umol/l

0.17

139

1128

Fracture of shoulder and upper arm

150

1221

1.23

1.70

1.3

1.4

14.60

12.78

umol/l

1.77

139

1150

Injuries to the shoulder and upper arm

394

2677

1.14

1.69

1.4

13.62

12.47

umol/l

2.11

369

2528

Varicella [chickenpox]

141

1.71

1.68

1.3

1.7

11.71

12.27

umol/l

0.21

131

Other specific arthropathies, wide

2.20

1.68

1.2

1.4

9.27

11.45

umol/l

1.68

Radiculopathy

450

1.38

1.68

1.3

1.5

14.76

12.89

umol/l

0.98

414

Diabetes medication

489

2545

1.12

1.68

1.4

13.58

11.98

umol/l

4.49

449

2429

Degenerative macular diseases

284

1.48

1.66

1.4

1.5

13.80

13.94

umol/l

0.04

262

Colorectal cancer, including Hilmo

669

1.30

1.66

1.4

1.5

14.31

14.16

umol/l

0.05

622

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

2.46

1.65

1.3

1.7

11.09

13.93

umol/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

105

826

1.27

1.64

1.5

1.4

11.94

12.53

umol/l

0.52

782

Degeneration of macula and posterior pole

168

1070

1.21

1.64

1.3

1.4

13.85

14.27

umol/l

0.33

153

998

Varicella [chickenpox], including avohilmo

173

1.62

1.63

1.3

1.6

11.47

11.64

umol/l

0.06

162

Embedded and impacted teeth

136

893

1.24

1.62

1.4

11.98

10.74

umol/l

0.97

130

846

Other and unspecified vasculitis limited to skin

2.16

1.61

1.1

1.6

14.31

13.85

umol/l

0.07

Other misadventures during surgical and medical care

2.08

1.60

1.3

1.7

12.19

13.45

umol/l

0.50

Type 1 diabetes, wide definition

749

1.28

1.59

1.4

13.27

11.64

umol/l

1.06

713

Methotrexate

370

1.41

1.59

1.1

1.5

14.72

12.12

umol/l

1.67

348

Other acquired deformities of ankle and foot

3.04

1.59

1.3

1.5

14.67

10.62

umol/l

—

Diabetes insipidus

3.03

1.58

1.3

1.9

8.55

11.94

umol/l

—

Iridocyclitis

742

1.28

1.58

1.5

1.4

12.09

12.56

umol/l

0.27

699

Schizophrenia or delusion

140

1144

1.23

1.58

1.2

1.4

13.10

12.09

umol/l

0.58

113

1091

Schizophrenia, schizotypal and delusional disorders

140

1144

1.23

1.58

1.2

1.4

13.10

12.06

umol/l

0.60

113

1091

Congenital malformations of great arteries

2.22

1.57

1.3

1.9

13.44

10.08

umol/l

0.81

Adrenocortical insufficiency

1.86

1.56

1.3

1.5

11.13

12.23

umol/l

0.34

Pleural plaque with presence of asbestos

160

0.44

1.53

1.4

1.5

13.80

16.91

umol/l

—

144

Diseases of middle ear and mastoid

273

1934

1.15

1.52

1.3

1.4

11.77

11.76

umol/l

0.01

255

1835

Other intervertebral disc disorders

372

1959

1.13

1.52

1.4

12.87

12.32

umol/l

0.71

350

1850

Clubfoot

2.89

1.51

1.3

1.5

14.83

9.96

umol/l

—

Dronedarone medication

2.17

1.51

1.2

1.4

15.11

15.04

umol/l

0.01

Molar incisor enamel hypoplasia, with caries

2.60

1.50

1.3

1.4

9.69

7.97

umol/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

116

1.73

1.49

1.4

1.5

11.61

11.26

umol/l

0.10

107

Other specified disorders of muscle

2.01

1.49

1.5

13.57

12.62

umol/l

0.18

Allergic urticaria

259

1.47

1.48

1.4

1.5

11.90

11.18

umol/l

0.25

243

Impacted cerumen

326

1.41

1.46

1.4

1.5

13.58

13.49

umol/l

0.03

307

Testicular dysfunction

140

1.65

1.45

1.7

1.5

13.48

13.30

umol/l

0.03

134

Other obstructed labour

241

0.54

1.45

1.2

1.4

10.37

10.53

umol/l

0.05

228

Chronic periodontitis, complicated

237

1995

1.16

1.44

1.3

1.4

14.89

12.96

umol/l

3.65

217

1886

Otitis externa, unspecified

369

1.39

1.44

1.2

1.5

12.20

11.85

umol/l

0.13

350

Other abnormal products of conception

149

808

1.21

1.44

1.3

1.4

9.77

9.96

umol/l

0.18

144

775

Hypertensive heart and/or renal disease

495

1.28

1.44

1.3

1.5

18.35

13.28

umol/l

4.48

459

Fibroblastic disorders

673

1.28

1.44

1.4

1.5

12.33

13.67

umol/l

1.05

625

Other congenital malformations of circulatory system

1.98

1.43

1.2

1.7

10.91

12.85

umol/l

0.51

Fall involving bed

1.98

1.43

1.6

1.5

14.48

15.08

umol/l

0.08

Other diseases of lip and oral mucosa

181

1534

1.18

1.42

1.4

11.67

12.37

umol/l

0.95

167

1452

Alcohol abuse, main dg, excluding more controls

448

1.34

1.41

1.1

1.5

14.25

13.12

umol/l

0.45

429

Open wound of forearm

312

1.41

1.40

1.3

1.5

12.97

12.80

umol/l

0.05

293

Seropositive rheumatoid arthritis, wide

765

1.26

1.39

1.3

1.5

11.87

12.96

umol/l

0.96

719

Acute and subacute iridocyclitis

606

1.29

1.39

1.6

1.5

12.48

12.44

umol/l

0.01

570

Gonarthrosis,primary

296

2028

0.88

1.38

1.4

13.70

13.15

umol/l

0.66

282

1909

Hernia of abdominal wall

187

1594

1.17

1.38

1.2

1.4

14.14

13.00

umol/l

1.24

178

1501

Impacted teeth

100

687

1.25

1.37

1.4

12.44

10.82

umol/l

0.96

652

Drug-induced adrenocortical insufficiency

2.21

1.37

1.2

1.8

10.38

11.96

umol/l

—

Impacted maxillary canine

2.64

1.37

1.0

1.5

24.33

9.48

umol/l

—

Otitis externa

794

1.25

1.37

1.2

1.4

11.78

12.47

umol/l

0.54

752

Anterior Iridocyclitis

652

1.28

1.36

1.5

12.24

12.56

umol/l

0.14

612

Subacute thyroiditis

1.84

1.36

1.8

1.4

10.37

11.54

umol/l

0.31

Unspecified maternal hypertension

0.00

1.35

0.0

1.4

—

10.49

—

Other disorders of bone density and structure

1.88

1.34

1.4

1.6

12.80

11.56

umol/l

0.17

Other localized connective tissue disorders

2.16

1.34

1.2

1.9

11.43

12.44

umol/l

—

Exposure to other specified electric current

1.92

1.33

1.5

1.6

10.88

11.05

umol/l

0.06

Rheumatic fever incl heart disease

1.92

1.33

1.4

1.6

13.33

14.41

umol/l

0.17

Diffuse brain injury

1.92

1.33

1.2

1.6

12.67

13.77

umol/l

0.22

Fracture of neck

152

1.58

1.31

1.6

12.15

13.95

umol/l

0.90

139

Macular pucker

411

1.34

1.30

1.4

1.5

12.74

14.19

umol/l

0.87

379

Substance abuse

261

2128

1.14

1.30

1.3

1.4

14.13

12.56

umol/l

2.03

226

2025

Disease of hard tissues of teeth, NOS

230

1042

1.16

1.29

1.4

12.42

12.63

umol/l

0.18

207

986

Corns and callosities

185

1.52

1.29

1.6

13.88

13.07

umol/l

0.22

173

Fracture of lower leg, including ankle

242

2078

1.14

1.28

1.3

1.4

12.85

12.53

umol/l

0.30

218

1959

Systemic sclerosis, icd10

2.01

1.27

1.2

1.5

13.49

10.54

umol/l

0.69

Systemic sclerosis

2.01

1.27

1.2

1.5

13.49

9.95

umol/l

0.88

Panniculitis affecting regions of neck and back

1.73

1.27

1.5

14.36

11.97

umol/l

0.49

Substance use, excluding alcohol

713

1.25

1.26

1.2

1.5

14.45

12.17

umol/l

1.10

681

Melanoma in situ

107

1.69

1.26

1.7

1.6

12.91

14.50

umol/l

0.42

Persons encountering health services in circumstances related to reproduction

275

1624

1.14

1.25

1.6

1.4

10.88

12.29

umol/l

4.17

266

1546

Algoneurodystrophy

1.75

1.25

1.6

1.4

13.19

10.62

umol/l

0.57

Noise effects on inner ear

117

0.43

1.25

1.2

1.5

13.60

14.26

umol/l

—

112

Medical abortion

260

1233

1.14

1.25

1.3

1.4

11.15

11.14

umol/l

0.00

244

1174

Missing teeth due to accident, extraction or parodontitis

249

1953

1.14

1.23

1.4

13.61

13.06

umol/l

0.66

224

1844

Rare circulating lymphoid malignancy, including Hilmo

1.91

1.23

1.2

1.7

14.95

13.38

umol/l

0.28

Premature rupture of membranes

611

0.78

1.23

1.7

1.3

9.25

9.96

umol/l

0.58

582

Varicose veins

225

1481

1.15

1.22

1.3

1.4

13.81

13.00

umol/l

0.85

208

1383

Thiazolidinediones

313

1.38

1.22

1.3

1.5

15.63

13.50

umol/l

0.73

295

Chronic diseases of tonsils and adenoids

371

2102

1.11

1.21

1.3

1.4

11.29

12.34

umol/l

2.61

351

1995

Carcinoma in situ of skin

205

1.47

1.19

1.6

1.5

14.80

14.10

umol/l

0.25

184

Vertical strabismus

1.75

1.19

1.2

1.5

11.27

11.76

umol/l

0.13

Spinal enthesopathy

2.11

1.18

1.3

1.5

12.06

13.92

umol/l

—

Other/unspecified seropositive rheumatoid arthritis

756

1.23

1.18

1.3

1.5

11.86

12.93

umol/l

0.89

710

Corneal ulcer

622

1.26

1.17

1.4

1.5

13.45

12.12

umol/l

0.79

588

Mixed disorders of conduct and emotions, excluding more controls

1.94

1.17

1.5

1.8

8.96

9.75

umol/l

0.21

Mental and behavioural disorders due to psychoactive substance use

267

2168

1.13

1.16

1.3

1.4

14.14

12.52

umol/l

2.17

232

2061

Dissociative [conversion] disorders

102

1.67

1.16

1.4

1.6

11.08

10.35

umol/l

0.12

Diabetic neuropathy

323

1.36

1.16

1.2

1.4

14.78

14.79

umol/l

0.00

302

Diabetes, insulin treatment (Kela reimbursement)

455

2465

1.10

1.15

1.3

1.4

14.45

12.13

umol/l

7.56

420

2346

Hypertensive Heart Disease

458

1.26

1.14

1.4

1.5

17.55

13.38

umol/l

3.36

425

Respiratory conditions due to other external agents

2.01

1.12

1.6

1.7

11.96

13.88

umol/l

—

Graves ophthalmopathy, strict

1.97

1.11

1.1

1.5

9.88

10.52

umol/l

—

Early onset COPD

663

1.24

1.11

1.4

16.08

13.39

umol/l

1.65

623

Localized scleroderma [morphea]

2.27

1.10

1.1

1.9

9.99

12.32

umol/l

—

Lichen sclerosus et atrophicus

337

1.34

1.09

1.5

10.29

11.84

umol/l

1.29

317

Unspecified threat to breathing

2.40

1.09

1.8

1.9

9.00

10.18

umol/l

—

Injury of muscle and tendon at shoulder and upper arm level

141

1203

1.17

1.09

1.5

1.4

12.40

13.58

umol/l

1.47

132

1130

Other sexually transmitted chlamydial diseases, including avohilmo

372

1.32

1.09

1.3

1.4

10.64

10.54

umol/l

0.05

353

Contusion of toe(s) with damage to nail

2.20

1.08

1.3

1.6

11.16

10.99

umol/l

—

Other and unspecified disorders of psychological development

2.20

1.08

1.0

1.8

8.71

8.45

umol/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

701

1.22

1.07

1.2

1.4

16.26

14.66

umol/l

0.82

642

Operations 2 for CAVS

701

1.22

1.07

1.2

1.4

16.26

14.66

umol/l

0.82

642

Other hearing loss

767

1.21

1.07

1.5

1.4

14.76

14.11

umol/l

0.26

709

Chronic lymphocytic leukaemia, helper endpoint

1.87

1.07

1.8

1.7

12.73

15.47

umol/l

0.71

Chronic lymphocytic leukaemia

1.87

1.07

1.8

1.7

12.73

15.47

umol/l

0.71

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

1.87

1.07

1.8

1.7

12.73

15.47

umol/l

0.71

Adenocarcinoma of pancreas

1.87

1.07

1.5

1.7

11.54

14.31

umol/l

0.57

Amputation of thigh

1.87

1.07

1.3

1.6

17.64

16.18

umol/l

0.18

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

126

1067

1.18

1.07

1.4

1.5

13.36

12.56

umol/l

0.57

118

1004

Pervasive developmental disorders excl. Autism + Asperger

2.17

1.07

1.7

8.23

9.72

umol/l

—

Dental pulpitis, including avohilmo

376

2648

0.91

1.06

1.3

1.4

12.54

12.02

umol/l

0.76

354

2507

Calcific aortic valvular stenosis

702

1.22

1.06

1.2

1.4

16.26

14.64

umol/l

0.83

643

Calcific aortic valvular stenosis, operated

702

1.22

1.06

1.2

1.4

16.26

14.64

umol/l

0.83

643

Malignant neoplasm of head and neck, including Hilmo

254

1.38

1.04

1.2

1.6

14.17

14.47

umol/l

0.08

234

Deficiency of other B group vitamins

1.97

1.03

1.7

1.8

16.29

13.39

umol/l

—

Conductive and sensorineural hearing loss

264

1959

0.89

1.03

1.4

12.46

13.21

umol/l

1.12

249

1846

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

751

1.21

1.03

1.3

1.5

11.97

12.84

umol/l

0.67

705

Calcific aortic valvular stenosis, including rheumatic fever

704

1.22

1.03

1.2

1.4

16.26

14.66

umol/l

0.82

645

Graves ophthalmopathy

1.84

1.03

1.1

1.5

9.80

10.71

umol/l

0.20

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.84

1.03

1.1

1.5

9.80

10.44

umol/l

0.13

Adenocarcinoma and ductal carcinoma of pancreas

1.74

1.03

1.5

1.7

11.68

14.06

umol/l

0.58

COPD, hospital admissions 1, only main diagnosis

113

817

1.19

1.02

1.2

1.4

18.35

14.10

umol/l

3.91

103

758

Combinations of oral blood glucose lowering drugs

101

844

1.20

1.01

1.3

1.5

15.47

13.39

umol/l

1.64

802

COPD

157

1103

1.16

1.01

1.3

1.5

17.05

13.65

umol/l

4.11

144

1027

Benign lipomatous neoplasm

113

955

1.18

1.00

1.3

1.5

12.43

12.95

umol/l

0.35

101

901

Atopic dermatitis, strict definition

139

1169

1.16

0.99

1.5

1.4

10.82

11.04

umol/l

0.18

133

1118

Motor disorders, excluding more controls

2.00

0.99

1.3

1.8

7.14

9.49

umol/l

—

Pleural plaque

213

0.61

0.99

1.2

1.5

16.68

16.03

umol/l

0.07

193

Malignant neoplasm of skin

182

1077

1.14

0.99

1.4

13.88

13.50

umol/l

0.25

174

1006

Systemic sclerosis (FG)

1.81

0.98

1.2

1.5

13.49

11.32

umol/l

0.45

Urticaria

131

1123

1.17

0.98

1.3

1.5

10.87

11.60

umol/l

0.75

125

1066

Diabetic retinopathy, excluding more controls

100

466

1.20

0.96

1.4

14.17

14.27

umol/l

0.04

433

Chronic nephritic syndrome

108

1.58

0.96

1.1

1.6

19.47

13.08

umol/l

1.49

101

COPD, hospital admissions 3, with asthma pneumonia sepsis

609

1.21

0.96

1.2

1.4

18.74

14.41

umol/l

2.84

562

Other menopausal disorders

455

1.20

0.95

1.4

10.67

12.05

umol/l

1.24

433

Crowding of teeth, including avohilmo

278

1.31

0.95

1.3

1.4

10.73

10.01

umol/l

0.27

265

Hyperprolactinaemia

1.62

0.94

1.1

1.5

10.23

10.49

umol/l

0.07

Benign neoplasm: Scapula and long bones of upper limb

2.24

0.94

1.0

1.6

13.62

10.88

umol/l

—

Sensorineural hearing loss

246

1826

0.90

0.93

1.4

12.48

13.36

umol/l

1.36

232

1716

Deviated nasal septum

137

1184

1.16

0.93

1.2

1.4

12.67

13.34

umol/l

0.72

127

1119

Habit and impulse disorders

1.74

0.92

1.3

1.8

15.77

11.12

umol/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.83

0.92

1.4

1.6

11.92

14.05

umol/l

—

Hyperplasia of prostate

128

617

1.17

0.92

1.4

14.96

15.02

umol/l

0.03

115

587

Later onset COPD, excluding more controls

358

1.26

0.92

1.2

1.5

19.21

14.40

umol/l

2.76

332

Meralgia paraesthetica

1.63

0.91

1.9

1.5

13.12

12.41

umol/l

0.14

Papulosquamous disorders

159

1394

1.14

0.90

1.4

12.77

12.54

umol/l

0.15

150

1318

Other bullous disorders

1.75

0.90

1.0

1.7

14.15

13.70

umol/l

0.05

Periodontitis

443

2606

1.08

0.89

1.3

1.4

14.28

12.20

umol/l

6.79

408

2472

Hypoplasia of dental enamel

2.08

0.89

1.2

1.3

9.47

8.03

umol/l

—

Ingrowing nail

177

1.42

0.88

1.9

1.5

13.60

12.12

umol/l

0.48

165

Other fall from one level to another

802

1.19

0.88

1.2

1.5

12.36

12.47

umol/l

0.05

756

Excessive earwax

255

2087

1.11

0.87

1.5

1.4

12.35

13.03

umol/l

1.04

229

1980

Tuberculosis of other organs, strict, including avohilmo

1.87

0.87

1.3

1.8

15.81

14.85

umol/l

—

Palmar fascial fibromatosis [Dupuytren]

395

1.27

0.87

1.4

13.40

14.44

umol/l

0.41

363

Other melanin hyperpigmentation

1.83

0.86

2.1

1.7

12.13

12.75

umol/l

—

Coxarthrosis, primary, with hip surgery

124

1325

0.87

0.85

1.5

1.4

13.30

13.88

umol/l

0.46

114

1238

Kela-code for severe mental illness

151

1326

1.14

0.85

1.3

1.4

13.22

12.03

umol/l

0.77

121

1263

Caries of dentine, including avohilmo

343

1605

1.09

0.84

1.4

12.70

12.29

umol/l

0.50

321

1518

Alcohol use disorder, Swedish definition

229

1875

1.11

0.83

1.3

1.4

14.27

12.85

umol/l

1.71

201

1782

Fracture of foot, except ankle

105

900

1.17

0.83

1.5

1.4

12.27

12.05

umol/l

0.13

853

Lesion of ulnar nerve

434

1.25

0.83

1.3

1.5

13.12

12.67

umol/l

0.19

407

Other (not insulin) diabetes medications

429

2330

1.08

0.83

1.3

1.4

13.91

12.15

umol/l

4.83

392

2220

Carcinoma in situ of cervix uteri

330

0.73

0.81

1.5

1.4

11.84

9.71

umol/l

0.76

307

Malignant neoplasm of skin, including Hilmo

192

1147

1.12

0.81

1.4

13.81

13.29

umol/l

0.39

184

1074

Vascular syndromes of brain in cerebrovascular disorders

1.58

0.81

1.4

1.5

17.31

15.73

umol/l

0.20

Diseases of pulp and periapical tissues, including avohilmo

481

2313

1.08

0.81

1.3

1.4

12.96

12.10

umol/l

1.82

451

2189

Bronchiectasis

206

1.36

0.81

1.2

1.6

14.23

13.60

umol/l

0.18

190

Disorders of orbit

122

1.48

0.80

1.1

1.6

13.07

12.08

umol/l

0.18

114

Chronic periodontitis, including avohilmo

440

2606

1.08

0.80

1.3

1.4

14.34

12.20

umol/l

7.00

403

2473

Malignant neoplasm of oesophagus

1.73

0.79

1.1

1.7

14.31

14.84

umol/l

—

Disorders of synovium and tendon

223

1707

1.11

0.79

1.4

11.02

12.46

umol/l

3.74

211

1604

Poisoning by medicine

803

1.17

0.79

1.2

1.4

12.08

11.64

umol/l

0.20

766

Other specified/unspecified deforming dorsopathies

1.67

0.79

1.4

1.3

10.44

11.10

umol/l

—

Other renal tubulo-interstitial diseases

1.67

0.79

1.2

1.5

20.15

10.82

umol/l

1.38

Protozoal diseases

1.63

0.78

1.5

1.7

14.70

13.47

umol/l

0.18

Malignant neoplasm of mesothelium and soft tissue

1.56

0.78

1.5

1.7

13.16

14.23

umol/l

0.17

Pustulosis palmaris et plantaris

122

0.57

0.78

1.1

1.5

13.49

12.05

umol/l

—

113

COPD, hospital admission 2, with asthma infections

104

771

1.16

0.77

1.3

1.4

17.65

14.10

umol/l

2.64

712

Gonarthrosis, primary, with knee surgery

171

1490

0.89

0.77

1.4

14.18

13.60

umol/l

0.48

163

1395

Other acute viral hepatitis

1.77

0.76

1.8

1.6

13.38

10.95

umol/l

—

Other chronic obstructive pulmonary disease

146

1055

1.13

0.76

1.3

1.5

17.29

13.69

umol/l

4.12

134

981

Sub-endpoint used in defining T1D endpoints

115

985

1.15

0.76

1.4

13.36

12.47

umol/l

0.53

107

933

Vasomotor and allergic rhinitis

164

1428

1.12

0.76

1.3

1.4

10.79

11.83

umol/l

1.42

156

1358

Isolated patent ductus arteriosus

2.16

0.76

1.2

2.4

11.56

10.84

umol/l

—

severe traumatic brain injury, does not include concussion

640

1.19

0.76

1.4

13.37

13.93

umol/l

0.34

593

Medical treatment for female infertility

763

1.17

0.75

1.4

1.3

9.19

9.85

umol/l

0.72

729

Other lesions of median nerve

1.67

0.74

1.1

1.6

13.11

12.80

umol/l

—

Psoriasis vulgaris

614

1.19

0.74

1.3

1.5

13.67

12.72

umol/l

0.47

578

Wide developmental disorders, excluding more controls

1.54

0.74

1.6

1.7

10.27

10.46

umol/l

0.05

Abnormal findings in secretions and smears from cervix uteri vagina vulva

204

1354

1.11

0.74

1.3

1.4

11.21

10.66

umol/l

0.51

194

1284

COPD related to multimorbidity

127

942

1.14

0.74

1.3

1.4

17.89

14.14

umol/l

3.53

116

876

Injuries to the neck

837

1.16

0.73

1.4

11.66

12.09

umol/l

0.38

793

Exclusion endpoint for supernumerary teeth

2.01

0.73

1.4

1.6

12.44

10.53

umol/l

—

Asthma and opportunity respiratory infection

125

1.44

0.72

1.1

1.6

14.06

13.97

umol/l

0.02

115

Allergic purpura

1.55

0.72

1.2

1.6

13.96

12.15

umol/l

0.48

Hypertrophy of breast in women and men

672

1.18

0.72

1.3

1.4

9.97

11.23

umol/l

1.73

639

Protozoal diseases, including avohilmo

1.58

0.71

1.5

1.7

14.70

13.24

umol/l

0.21

Mental and behavioural disorders due to alcohol, excluding acute intoxication

181

1615

1.11

0.71

1.3

1.4

14.33

13.01

umol/l

1.32

156

1535

Diseases of pulp and periapical tissues and dental caries

280

1316

1.09

0.71

1.4

13.17

12.47

umol/l

0.87

265

1241

Vasomotor rhinitis (mode)

229

0.70

1.1

1.5

10.41

12.23

umol/l

0.81

214

Basal cell carcinoma

154

935

1.12

0.70

1.4

1.5

13.93

13.68

umol/l

0.14

149

870

Allergic rhinitis

138

1209

1.13

0.70

1.3

1.4

10.33

11.32

umol/l

1.24

130

1150

Diabetic maculopathy, excluding more controls

318

1.26

0.70

1.3

1.5

13.62

12.56

umol/l

0.33

299

245

2001

1.09

0.70

1.3

1.4

14.05

12.76

umol/l

1.67

216

1902

Inflammatory disease of cervix uteri

181

0.66

0.69

1.8

1.4

9.98

10.87

umol/l

0.42

168

Venous complications and haemorrhoids in pregnancy

1.65

0.68

1.2

1.4

13.26

9.58

umol/l

—

Congenital malformations of the nervous system

1.65

0.68

1.2

1.7

11.74

10.03

umol/l

—

Intentional self-harm by sharp object

1.56

0.68

1.2

1.5

8.72

10.33

umol/l

0.79

Benign neoplasm: Liver

1.65

0.68

1.4

1.6

10.55

11.48

umol/l

—

Other and unspecified epidermal thickening

1.65

0.68

1.0

1.7

17.53

13.36

umol/l

—

False labour

106

752

0.87

0.68

1.4

1.3

9.82

10.08

umol/l

0.20

101

719

Primary gonarthrosis, bilateral

153

1428

0.90

0.67

1.4

13.20

13.44

umol/l

0.18

143

1334

Tuberculosis of other organs, strict

1.63

0.67

1.3

1.8

16.87

14.85

umol/l

—

Basal cell carcinoma, including Hilmo

161

978

1.11

0.66

1.4

14.21

13.65

umol/l

0.37

156

913

Glaucoma suspect

1130

0.87

0.66

1.4

12.34

13.31

umol/l

0.74

1060

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

241

1717

1.09

0.65

1.3

1.4

11.43

11.61

umol/l

0.15

228

1624

Mental and behavioural disorders due to alcohol

213

1853

1.09

0.65

1.3

1.4

14.04

12.75

umol/l

1.50

185

1763

Alzheimer’s disease (Atypical or mixed)

199

0.69

0.65

1.2

1.4

15.36

16.06

umol/l

0.07

180

Other and unspecified urticaria

689

1.16

0.64

1.4

1.5

10.78

11.62

umol/l

0.74

655

Other appendicitis

270

0.74

0.64

1.5

13.15

12.50

umol/l

0.11

253

Mouth breathing

161

1452

1.11

0.63

1.4

12.29

12.83

umol/l

0.52

150

1376

COPD, hospital admissions

146

1104

1.11

0.62

1.3

1.4

17.44

13.96

umol/l

3.81

135

1028

Cysts of oral region, not elsewhere classified

188

0.69

0.62

1.2

1.5

10.78

12.51

umol/l

0.79

177

Idiopathic urticaria

1.56

0.62

1.2

1.6

8.15

11.01

umol/l

1.61

Perioral dermatitis

1.56

0.62

1.5

13.44

9.66

umol/l

0.93

Benign neoplasm: Liver/bile ducts

1.55

0.62

1.4

1.6

11.23

11.82

umol/l

0.18

Stomatitis and related lesions

674

1.16

0.61

1.3

1.5

12.04

11.85

umol/l

0.10

637

Complications of labour and delivery

216

1309

0.92

0.61

1.4

10.23

11.27

umol/l

1.99

201

1242

Other benign neoplasms of skin

136

1220

1.12

0.61

1.4

12.83

umol/l

0.00

126

1143

Male infertility

187

0.69

0.61

1.8

1.6

12.48

13.07

umol/l

0.24

181

Impetigo

156

1.35

0.61

1.4

1.7

11.80

11.56

umol/l

0.06

144

COPD, early/later onset

147

1110

1.11

0.61

1.3

1.4

17.44

13.97

umol/l

3.81

135

1035

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.60

0.0

2.0

—

13.40

—

Xanthelasma of eyelid

0.00

0.60

0.0

2.0

—

11.04

—

Alcohol use disorder, ICD-based

167

1517

1.10

0.60

1.3

1.4

14.59

12.96

umol/l

1.67

145

1439

Polyhydramnios

151

0.66

0.59

1.2

1.4

13.00

9.50

umol/l

—

141

Viral encephalitis, not elsewhere classified/unspecified

1.54

0.59

1.8

1.7

12.35

12.52

umol/l

—

Benign neoplasm: Tongue

1.53

0.59

1.4

1.6

11.04

13.38

umol/l

1.30

Contraceptive management

182

1159

1.10

0.58

1.4

10.55

11.89

umol/l

3.06

175

1110

Open wound of wrist and hand

171

1812

0.91

0.58

1.3

1.4

11.44

12.54

umol/l

1.58

164

1709

Endometriosis of fallopian tube

0.00

0.58

0.0

1.2

—

10.45

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

1.51

0.58

1.7

12.35

12.49

umol/l

—

Other blood glucose lowering drugs, excl. Insulins

418

1.20

0.58

1.3

1.5

13.92

13.37

umol/l

0.18

398

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

603

1.16

0.58

1.2

1.4

11.64

11.50

umol/l

0.04

575

Idiopathic pulmonary fibrosis

175

1.32

0.58

1.2

1.5

14.53

15.64

umol/l

0.28

159

Maternal care for known or suspected malpresentation of fetus

548

0.86

0.58

1.5

1.3

9.41

9.89

umol/l

0.35

521

Congenital malformations of breast

1.49

0.57

1.5

1.6

7.41

9.34

umol/l

—

Spontaneous rupture of synovium and tendon

230

0.74

0.57

2.1

1.5

11.94

12.77

umol/l

0.37

213

Ankylosing spondylitis, ICD10

283

1.24

0.56

1.4

1.5

11.40

12.13

umol/l

0.41

264

Femoral hernia

1.43

0.56

2.1

1.6

9.49

13.13

umol/l

2.56

Inguinal of femoral hernia, unilateral

1.51

0.56

2.4

1.6

9.80

13.34

umol/l

2.01

Inguinal hernia, unilateral

1.51

0.56

2.4

1.6

9.80

13.34

umol/l

2.01

Femoral hernia, unilateral

1.51

0.56

2.4

1.6

9.80

13.34

umol/l

2.01

Pedal cyclist injured in collision with motor vehicle

0.57

0.56

1.4

1.7

10.32

11.86

umol/l

—

Ankylosing spondylitis, strict definition

150

1.34

0.56

1.5

1.6

11.88

12.26

umol/l

0.13

145

Diseases of male genital organs

216

1000

1.09

0.55

1.4

14.19

13.76

umol/l

0.37

200

951

Benign neoplasm: Cranial nerves

1.54

0.55

1.1

1.7

13.90

13.23

umol/l

—

257

2076

1.08

0.55

1.3

1.4

14.07

12.67

umol/l

1.86

227

1976

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

1.58

0.54

1.3

1.8

16.55

14.79

umol/l

—

Fall on and from ladder

204

1.28

0.54

1.3

1.6

14.04

14.46

umol/l

0.09

186

Carrier of infectious disease

1.49

0.53

1.9

1.7

11.11

11.70

umol/l

0.16

Asthma/COPD (KELA code 203)

426

2690

1.06

0.53

1.3

1.4

13.06

12.09

umol/l

1.62

399

2544

Unknown and unspecified causes of morbidity

160

1.31

0.53

1.1

1.5

13.49

12.04

umol/l

0.28

151

Other and unspecified nail disorders

1.46

0.53

1.2

1.7

12.30

12.05

umol/l

—

Melanocytic naevi of scalp and neck

1.52

0.52

1.3

1.6

9.31

11.93

umol/l

—

Urethral stricture

143

1.33

0.52

1.4

1.6

15.99

14.60

umol/l

0.27

133

Infections of genitourinary tract in pregnancy

304

0.79

0.52

1.3

1.4

9.82

10.12

umol/l

0.15

287

Pustular psoriasis

135

0.67

0.51

1.1

1.5

12.93

11.92

umol/l

—

125

Juvenile rheumatoid arthirtis

1.41

0.51

1.3

1.4

11.81

10.08

umol/l

—

Fall on same level involving ice and snow

237

2204

1.07

0.51

1.3

1.4

12.52

12.50

umol/l

0.01

223

2080

Chondropathies

527

1.16

0.51

1.4

1.5

13.36

11.85

umol/l

0.76

495

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

154

1459

0.91

0.51

1.3

1.4

12.04

10.64

umol/l

1.79

147

1383

Viral meningitis

109

1.38

0.51

1.1

1.6

13.35

10.38

umol/l

1.06

100

Erythema nodosum

1.47

0.50

1.3

1.5

12.33

11.51

umol/l

0.13

Other malignant neoplasms of skin (=non-melanoma skin cancer)

156

967

1.09

0.50

1.4

1.5

13.82

13.75

umol/l

0.04

150

902

Dental operations

252

1206

1.07

0.50

1.4

13.15

12.76

umol/l

0.37

237

1134

Effects of foreign body entering through natural orifice

877

1.12

0.49

1.5

13.25

12.71

umol/l

0.33

831

Maternal care for known or suspected disproportion

144

0.69

0.49

1.8

1.3

8.94

9.73

umol/l

—

133

Open wound of hip and thigh

107

0.65

0.48

1.6

11.00

11.84

umol/l

—

Medial epicondylitis

107

0.65

0.48

1.1

1.4

17.43

12.00

umol/l

—

101

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

172

1.28

0.48

1.6

12.11

13.88

umol/l

0.53

154

Nontoxic goitre/thyroid nodule

889

1.11

0.47

1.3

1.4

10.74

12.55

umol/l

2.43

832

Obstructed labour due to malposition and malpresentation of fetus

784

0.88

0.47

1.4

1.3

9.69

10.25

umol/l

0.52

747

Appendectomy

280

2504

1.06

0.47

1.3

1.4

11.67

12.02

umol/l

0.41

269

2371

Poisoning by drugs, medicaments and biological substances

881

1.11

0.46

1.2

1.4

12.35

11.56

umol/l

0.42

840

Long labour

780

0.89

0.46

1.3

11.04

10.32

umol/l

0.47

744

Other obstetric trauma

164

1.28

0.46

1.3

10.94

9.71

umol/l

0.68

155

Inguinal hernia

239

1483

1.07

0.46

1.4

1.5

13.53

13.13

umol/l

0.38

225

1400

Dental caries, including avohilmo

304

1465

1.06

0.45

1.4

13.10

12.41

umol/l

0.88

285

1382

Acute bronchiolitis

189

1.24

0.45

1.5

10.91

10.54

umol/l

0.12

182

Single spontaneous delivery

130

752

0.91

0.45

1.6

1.4

10.50

11.57

umol/l

1.28

119

713

Postpartum haemorrhage due to retained placenta

417

0.84

0.45

1.2

1.4

9.79

9.47

umol/l

0.21

397

Sudden idiopathic hearing loss

302

1.19

0.44

1.2

1.5

13.26

13.13

umol/l

0.03

282

Ankylosing spondylitis

293

1.20

0.44

1.4

1.5

11.40

12.52

umol/l

0.70

272

Other abnormal findings of blood chemistry

139

1.30

0.43

1.2

1.5

14.01

12.15

umol/l

0.39

130

Pregnancy with abortive outcome

255

1246

1.07

0.43

1.2

1.4

11.00

11.13

umol/l

0.11

239

1187

Dislocation, sprain and strain of joints and ligaments of knee

273

2326

1.06

0.43

1.3

1.4

11.63

11.99

umol/l

0.53

263

2205

Lichen planus, including avohilmo

574

1.13

0.42

1.4

1.5

11.75

12.79

umol/l

0.69

539

Pregnancy, childbirth and the puerperium

517

0.90

0.42

1.4

11.26

11.56

umol/l

0.15

492

Ovarian hyperstimulation (induction)

1.41

0.42

1.1

1.3

8.83

9.76

umol/l

—

Other congenital malformations of skin

131

1.30

0.42

1.1

1.5

8.04

11.12

umol/l

3.12

122

Mantle cell lymphoma, including Hilmo

1.52

0.41

1.2

1.8

19.40

15.61

umol/l

—

Cervical root disorders

0.00

0.41

0.0

2.2

—

11.98

—

Dislocation, sprain and strain of joints and ligaments of thorax

105

1.34

0.41

2.1

1.7

13.20

11.98

umol/l

0.18

Malignant neoplasm of small intestine

1.36

0.41

1.3

1.8

19.85

14.62

umol/l

—

Chronic mastoiditis

1.36

0.41

1.4

1.7

13.71

14.15

umol/l

—

Psoriasis

109

995

1.10

0.41

1.3

1.4

13.02

12.61

umol/l

0.24

102

941

Mandibular retrognathia AND surgery (BSSO)

1.40

0.41

1.2

1.5

10.33

10.14

umol/l

0.06

Viral meningitis, including avohilmo

114

1.32

0.40

1.1

1.6

13.35

10.26

umol/l

1.12

105

Pregnancy hypertension

140

1353

0.92

0.40

1.2

1.4

12.06

10.42

umol/l

2.15

135

1283

Congenital malformations of breast, including avohilmo

1.34

0.40

1.5

1.6

7.41

9.85

umol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

181

1386

1.07

0.40

1.3

1.4

16.40

13.55

umol/l

3.66

168

1298

Other disorders of ear

388

2390

1.05

0.40

1.4

12.12

12.68

umol/l

0.91

362

2262

Other hammer toe(s) (acquired)

405

1.15

0.39

1.2

1.4

13.42

13.05

umol/l

0.16

377

Exposure to other and unspecified animate mechanical forces

101

0.69

0.39

2.1

1.6

12.44

10.78

umol/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

122

1122

1.09

0.39

1.4

12.59

12.48

umol/l

0.05

114

1061

Malignant neoplasm of small intestine, including Hilmo

1.41

0.39

1.5

1.8

17.77

14.39

umol/l

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.39

0.0

2.5

—

8.51

—

Other and unspecified injuries of neck

0.00

0.39

0.0

1.8

—

10.56

—

Sciatica+with lumbago

208

1728

1.07

0.39

1.3

1.4

12.53

12.27

umol/l

0.24

196

1630

Autism spe, excluding more controls

1.41

0.39

1.8

1.7

10.52

10.27

umol/l

—

Trigeminal neuralgia

169

1.24

0.38

1.3

1.5

12.07

12.05

umol/l

0.00

158

Endovascular or surgical operations to intracerebral aneurysms

142

1.27

0.38

1.2

1.6

11.58

13.20

umol/l

0.60

132

Other enthesopathies

110

1009

1.09

0.38

1.2

1.4

11.98

12.42

umol/l

0.36

103

951

Granulomatous disorders of skin and subcutaneous tissue

1.33

0.37

1.3

1.6

8.73

11.08

umol/l

—

Anisometropia and aniseikonia

1.33

0.37

1.0

1.7

13.03

12.24

umol/l

—

Carcinoma in situ of skin of trunk

1.29

0.36

1.1

1.5

15.00

15.62

umol/l

—

Polycythaemia vera

1.29

0.36

1.0

1.8

9.79

14.04

umol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

123

1137

1.08

0.36

1.2

1.4

11.41

11.38

umol/l

0.02

105

1084

Other and unspecified hydrocephalus

1.43

0.35

1.3

1.9

11.87

12.63

umol/l

—

Contact with nonpowered hand tool

123

0.73

0.35

1.7

1.6

11.99

13.14

umol/l

—

118

Maternal care for known or suspected fetal abnormality and damage

534

1.11

0.35

1.1

1.3

9.07

9.84

umol/l

1.00

510

Infective bursitis

1.37

0.34

1.1

1.5

11.93

13.83

umol/l

—

Pediculosis, acariasis and other infestations, including avohilmo

651

1.11

0.34

1.3

1.5

11.07

11.53

umol/l

0.30

618

Coxarthrosis, primary

183

1612

0.94

0.33

1.4

13.60

13.72

umol/l

0.08

171

1510

Artificial joint re-operation

177

0.79

0.33

1.7

1.5

16.94

13.83

umol/l

0.56

164

Acute and transient psychotic disorders

403

0.87

0.33

1.1

1.5

11.30

11.80

umol/l

0.33

383

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

201

1.20

0.32

1.2

1.5

15.04

13.14

umol/l

0.40

187

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

159

1006

1.07

0.32

1.4

13.98

13.67

umol/l

0.18

153

941

Degenerative diseases of the nervous system

649

1.09

0.32

1.3

1.4

14.29

15.07

umol/l

0.39

598

Other and unspecified tonsillitis

158

1233

1.07

0.32

1.4

12.39

11.38

umol/l

0.68

147

1177

Ganglion

704

1.09

0.31

1.4

1.5

10.54

11.96

umol/l

1.58

660

Diseases of appendix

317

2715

1.04

0.31

1.3

1.4

12.29

12.20

umol/l

0.08

305

2564

L02BX Other hormone antagonists and related agents

131

0.76

0.30

1.3

1.5

15.24

16.68

umol/l

—

119

Alcohol abuse, main dg

542

1.11

0.30

1.1

1.5

14.25

12.79

umol/l

0.64

514

Lichen ruber planus, wide definition including periferal and oral lichen planus

686

1.09

0.30

1.4

1.5

11.64

12.84

umol/l

0.97

642

Malignant neoplasm of rectum, including Hilmo

306

1.14

0.29

1.2

1.5

14.92

14.35

umol/l

0.14

280

LSIL lesion of the cervix uteri, vagina or vulva

477

1.11

0.29

1.3

1.4

12.31

9.98

umol/l

1.05

449

Benign neoplasm: Long bones of lower limb

106

0.75

0.29

1.0

1.6

9.65

12.10

umol/l

—

Malignant neoplasm of head and neck

213

1.17

0.29

1.2

1.6

13.78

14.75

umol/l

0.28

195

Meniscus derangement

218

1377

1.05

0.28

1.5

1.4

12.20

12.74

umol/l

0.69

210

1302

Hypercalcemia

103

1.26

0.28

1.6

14.82

14.39

umol/l

0.04

Benign neoplasm of other and unspecified sites

1.30

0.28

1.3

1.6

9.00

12.17

umol/l

1.45

Other acute skin changes due to ultraviolet radiation

1.30

0.28

1.5

11.65

13.65

umol/l

0.48

Coxibs

120

588

1.07

0.28

1.5

1.4

12.10

13.93

umol/l

2.15

112

562

Myocardial infarction, unclassifiable

462

1.10

0.27

1.6

1.4

16.92

15.31

umol/l

0.58

424

Carpal tunnel syndrome

220

1995

0.95

0.27

1.3

1.4

12.33

12.42

umol/l

0.07

205

1889

Other vitreous opacities

121

0.74

0.27

1.0

1.5

13.32

13.65

umol/l

—

114

Diabetes mellitus in pregnancy

122

826

0.94

0.27

1.4

1.3

10.10

9.89

umol/l

0.15

117

795

Diffuse large B-cell lymphoma

122

1.23

0.27

1.3

1.7

18.41

14.65

umol/l

1.47

109

Diffuse large B-cell lymphoma, including Hilmo

122

1.23

0.27

1.3

1.7

18.41

14.65

umol/l

1.47

109

Diffuse large B-cell lymphoma, helper endpoint

122

1.23

0.27

1.3

1.7

18.41

14.65

umol/l

1.47

109

Short Achilles tendon (acquired)

1.21

0.26

1.1

1.4

8.99

11.57

umol/l

—

Enthesopathies of lower limb, excluding foot

818

1.08

0.26

1.6

1.5

12.15

12.19

umol/l

0.02

766

Suggestive for eosinophilic asthma

278

0.86

0.26

1.0

1.6

13.90

13.14

umol/l

0.19

257

Delivery, wide proxy

110

623

0.94

0.25

1.5

1.4

11.14

11.28

umol/l

0.07

101

588

Loose body in joint

1.20

0.25

1.1

1.4

12.37

13.71

umol/l

—

Bilateral sagittal split ramus osteotomy operation

105

1.24

0.25

1.5

9.69

10.07

umol/l

0.14

Malignant neoplasm of other connective and soft tissue, including Hilmo

105

1.24

0.24

1.8

1.7

12.85

13.96

umol/l

0.17

Unspecified urinary incontinence

245

1.14

0.24

1.3

1.5

14.05

12.09

umol/l

0.36

229

All dysplastic lesions of the vagina

1.17

0.24

2.1

1.4

15.20

10.42

umol/l

—

Crossbite

243

1.14

0.24

1.2

1.4

10.10

10.75

umol/l

0.26

232

Acute alcohol intoxication, ICD10

725

0.92

0.24

1.1

1.5

13.36

12.82

umol/l

0.25

690

Inflammatory diseases of prostate (prostatitis)

388

1.11

0.24

1.3

1.5

11.47

14.63

umol/l

5.00

370

Glucosamine medication

130

1095

0.95

0.23

1.3

1.4

13.09

13.90

umol/l

0.59

119

1026

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

119

1125

1.06

0.23

1.4

13.54

12.34

umol/l

1.26

111

1074

Glucagon-like peptide-1 (GLP-1) analogues

119

1125

1.06

0.23

1.4

13.54

12.34

umol/l

1.26

111

1074

Artificial joint operation, meniscal resection

342

2258

0.97

0.23

1.4

12.99

13.01

umol/l

0.02

328

2126

Superficial injury of wrist and hand

795

0.93

0.23

1.4

11.38

11.89

umol/l

0.43

754

Artrosis, including avohilmo

343

1939

0.97

0.22

1.4

12.58

12.49

umol/l

0.09

324

1837

Effects of other external causes

0.76

0.22

1.0

1.7

8.97

11.82

umol/l

—

Myasthenia gravis

1.22

0.22

1.2

1.7

12.66

13.59

umol/l

—

Schizophrenia

564

1.08

0.22

1.1

1.5

15.25

12.35

umol/l

0.88

535

Acute appendicitis

294

2637

1.03

0.22

1.3

1.4

12.19

12.15

umol/l

0.03

283

2491

Coxarthrosis [arthrosis of hip](FG)

193

1272

1.04

0.22

1.4

13.87

13.22

umol/l

0.53

181

1191

Suppurative and unspecified otitis media

155

1309

1.05

0.22

1.3

1.4

11.23

11.34

umol/l

0.07

146

1243

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.21

0.0

1.6

—

14.01

—

Nondiabetic hypoglycaemic coma

0.00

0.21

0.0

1.8

—

13.74

—

Necrosis of pulp, including avohilmo

237

2428

0.96

0.21

1.3

1.4

12.79

11.99

umol/l

1.06

223

2301

Pityriasis lichenoides chronica

0.00

0.21

0.0

1.5

—

12.00

—

Use of peginterferon beta-1a

0.00

0.21

0.0

1.8

—

9.06

—

Peroneal tendinitis

1.19

0.21

1.8

1.5

9.76

11.66

umol/l

—

Benign neoplasm: Testis

0.00

0.21

0.0

1.7

—

11.70

—

Other bursitis of hip

1.19

0.21

2.2

1.5

13.20

12.65

umol/l

—

Abnormal reflex

0.00

0.21

0.0

1.4

—

10.82

—

Maxillary prognathism

0.00

0.21

0.0

1.8

—

10.18

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.5

—

12.55

—

Personal history of allergy to analgesic agent

0.00

0.21

0.0

1.7

—

11.50

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

1.8

—

10.33

—

0.00

0.21

0.0

1.7

—

10.66

—

Scabies, including avohilmo

565

1.08

0.21

1.3

1.5

11.17

11.38

umol/l

0.11

537

Disorder of external ear, unspecified

101

0.79

0.21

2.5

1.5

17.63

13.12

umol/l

—

Periapical abscess

186

1785

1.04

0.21

1.3

1.4

13.23

12.41

umol/l

0.91

177

1694

Other dermatomyositis

0.00

0.21

0.0

1.5

—

13.31

—

Osteochondrosis of ankle, juvenile

0.00

0.21

0.0

1.9

—

9.23

—

Other congenital malformations of male genital organs, including avohilmo

0.00

0.21

0.0

1.7

—

10.92

—

Endometriosis of rectovaginal septum and vagina

192

1.15

0.20

1.2

1.4

10.66

11.68

umol/l

0.31

181

Abrasion of teeth

127

1334

0.95

0.20

1.4

12.28

12.13

umol/l

0.10

121

1262

Vaginal lichen planus

0.00

0.20

0.0

2.0

—

10.84

—

Carcinoma in situ of other and unspecified genital organs

1.25

0.20

1.2

1.6

9.57

11.53

umol/l

—

Infections of breast associated with childbirth

112

0.80

0.20

1.8

1.4

8.39

9.43

umol/l

—

103

Juvenile osteochondrosis

1.21

0.19

1.2

1.5

12.21

10.94

umol/l

0.31

Redundant prepuce, phimosis and paraphimosis

769

1.06

0.19

1.2

1.4

14.24

13.45

umol/l

0.44

731

Generalized epilepsy

133

0.83

0.19

1.0

1.6

9.62

11.45

umol/l

0.44

122

Astigmatism

212

1.13

0.19

1.1

1.5

13.87

11.79

umol/l

0.68

203

Autism

1.22

0.19

1.7

1.5

10.47

9.75

umol/l

0.18

Suicide or other Intentional self-harm

901

1.05

0.18

1.2

1.4

12.22

11.86

umol/l

0.16

858

Aggressive periodontitis

1.19

0.18

1.1

1.7

10.30

13.08

umol/l

—

Renal cell carcinoma of kidney

1.19

0.18

1.7

1.8

18.43

14.99

umol/l

—

Use of memantine

498

1.07

0.17

1.3

1.5

13.33

15.33

umol/l

1.66

459

Use of other anti-dementia drugs

498

1.07

0.17

1.3

1.5

13.33

15.33

umol/l

1.66

459

Appendicitis, broad definition

310

2705

1.03

0.17

1.3

1.4

12.32

12.17

umol/l

0.14

299

2555

Benign neoplasm: Conjunctiva

1.22

0.17

1.2

1.5

11.65

13.40

umol/l

—

Alcohol dependence

923

1.05

0.17

1.3

1.4

15.51

13.27

umol/l

1.44

875

Umbilical hernia

923

1.05

0.17

1.2

1.4

14.44

12.98

umol/l

1.11

873

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

272

1.10

0.17

1.2

1.5

13.06

11.91

umol/l

0.23

259

Gonarthrosis [arthrosis of knee](FG)

272

1610

0.97

0.17

1.3

1.4

13.26

12.69

umol/l

0.69

259

1515

Scabies

148

1.15

0.17

1.3

1.7

12.24

12.35

umol/l

0.04

141

Pyogenic arthritis

186

1.13

0.17

1.3

1.5

12.68

13.12

umol/l

0.15

172

Delivery

138

758

0.96

0.17

1.6

1.4

10.59

11.55

umol/l

1.07

127

719

Acute appendicitis, no complications

233

2246

1.03

0.16

1.3

1.4

12.08

12.03

umol/l

0.03

224

2124

Oter anti-inflammatory and antirheumatic agents, non-steroids

408

0.94

0.16

1.5

12.80

14.67

umol/l

1.26

391

Congenital malformations of uterus and cervix

1.13

0.16

1.3

1.6

7.17

9.85

umol/l

—

Brain meningioma, including Hilmo

130

0.85

0.16

1.2

1.7

10.31

12.66

umol/l

0.81

120

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

130

1.15

0.15

1.3

1.5

12.93

11.92

umol/l

0.30

121

Certain zoonotic bacterial diseases, including avohilmo

0.76

0.15

1.2

1.7

14.33

13.22

umol/l

—

Leiomyoma of uterus

232

1263

1.03

0.15

1.4

11.62

11.33

umol/l

0.22

215

1201

Primary open-angle glaucoma

806

1.05

0.15

1.4

12.58

14.28

umol/l

1.67

755

Acute alcohol intoxication

882

0.95

0.15

1.2

1.5

14.47

13.08

umol/l

0.82

838

Benign neoplasm: Skin of eyelid, including canthus

441

0.93

0.15

1.3

1.5

13.03

12.98

umol/l

0.02

411

Injury of nerves at wrist and hand level

129

0.85

0.14

1.3

1.6

13.09

12.77

umol/l

0.05

121

Other and unspecified corneal deformities and disorders

1.08

0.14

1.6

1.5

12.87

11.44

umol/l

—

Arthrosis

285

1522

1.03

0.14

1.3

1.4

12.74

12.44

umol/l

0.29

271

1439

Other and unspecified injuries of shoulder and upper arm

0.81

0.14

1.1

1.6

22.51

11.90

umol/l

—

Simple and mucopurulent chronic bronchitis

1.19

0.14

1.1

1.6

11.65

14.53

umol/l

—

Maternal care for known or suspected abnormality of pelvic organs

689

0.96

0.13

1.4

1.3

10.75

10.15

umol/l

0.41

657

Schizoaffective disorder

263

0.91

0.13

1.1

1.6

14.49

11.65

umol/l

0.49

250

Atopic conjunctivitis

132

1.14

0.13

1.5

11.59

10.59

umol/l

0.34

122

Brain meningioma

127

0.87

0.12

1.2

1.7

10.31

12.61

umol/l

0.78

117

Alzheimer’s disease (Atypical or mixed), excluding more controls

1.14

0.12

1.2

1.4

15.36

15.83

umol/l

0.04

Unspecified abortion

143

1.12

0.11

1.2

1.4

9.17

10.46

umol/l

0.87

135

Excessive attrition of teeth

256

2480

1.02

0.11

1.3

1.4

10.97

12.04

umol/l

2.59

245

2352

Other juvenile arthritis

126

0.87

0.11

1.4

1.5

13.45

9.95

umol/l

0.50

117

Malignant neoplasm of rectum

250

1.08

0.11

1.2

1.5

14.80

14.42

umol/l

0.09

228

Coxarthrosis

177

1113

1.03

0.11

1.4

14.05

13.21

umol/l

0.68

165

1049

Wide developmental disorders

124

1.13

0.10

1.6

1.5

10.27

9.76

umol/l

0.15

119

Gestational diabetes (for exclusion)

141

997

0.97

0.10

1.4

1.3

9.36

10.03

umol/l

1.19

132

957

Gonarthrosis

235

1355

0.98

0.10

1.3

1.4

13.42

12.71

umol/l

0.82

225

1279

Type of accident

107

1037

1.03

0.10

1.5

1.4

12.40

12.51

umol/l

0.05

983

Diabetic retinopathy

118

710

1.03

0.10

1.4

14.03

14.81

umol/l

0.50

108

660

Later onset COPD

544

0.96

0.10

1.2

1.4

19.25

15.22

umol/l

2.33

495

Contact with sharp glass

135

0.89

0.09

1.2

1.6

9.88

11.35

umol/l

0.55

126

Failed induction of labour

207

0.92

0.09

1.2

1.4

10.51

9.73

umol/l

0.16

195

Dislocation, sprain and strain of joint and ligaments of hip

1.15

0.09

1.6

14.23

13.29

umol/l

—

Malignant neoplasm of prostate, including Hilmo

483

0.96

0.09

1.3

1.5

14.68

15.44

umol/l

0.45

445

Haemorrhage in early pregnancy

980

0.97

0.09

1.4

1.3

12.13

10.46

umol/l

1.21

934

Cutaneous lupus erythematosus

1.07

0.08

1.3

1.6

12.60

11.65

umol/l

—

Acetic acid derivatives and related substances

107

569

0.97

0.08

1.3

1.4

12.56

13.85

umol/l

0.94

543

Other and unspecified injuries of lower leg

253

1.07

0.08

1.7

1.5

13.42

11.80

umol/l

0.69

243

Delayed milestone in childhood

0.81

0.08

1.2

1.7

12.80

8.90

umol/l

—

Other maternal disorders predominantly related to pregnancy

220

1351

1.02

0.08

1.4

1.3

11.15

10.81

umol/l

0.30

206

1287

Oral lichen planus

0.83

0.08

1.6

8.34

12.15

umol/l

—

Specific development disorders of scholastic skills

162

1.09

0.08

1.5

1.4

10.54

umol/l

0.00

154

Other and unspecified mononeuropathies of lower limb

0.78

0.08

1.4

1.6

19.40

12.48

umol/l

—

Contusion of toe(s) without damage to nail

1.14

0.08

1.2

1.4

10.18

10.92

umol/l

—

Haemorrhagic and haematological disorders of fetus and newborn

0.82

0.07

1.0

1.6

11.30

8.91

umol/l

—

Caught, crushed, jammed or pinched in or between objects

176

1.08

0.07

1.6

1.5

11.03

12.18

umol/l

0.58

164

Alcohol-induced acute pancreatitis

108

1.11

0.07

1.2

1.6

10.89

14.18

umol/l

1.63

103

Internal derangement of knee

140

1358

1.02

0.07

1.3

1.4

11.61

12.31

umol/l

0.78

132

1281

Other disorders of Eustachian tube

0.82

0.07

1.4

1.6

14.29

11.43

umol/l

—

Benign neoplasm: Skin, unspecified

118

1.10

0.07

1.2

1.5

17.42

12.55

umol/l

0.52

108

Autism spe

1.12

0.07

1.8

1.5

10.52

9.42

umol/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

175

1008

1.02

0.06

1.3

1.4

9.99

10.45

umol/l

0.59

168

959

Other specified disorders of external ear

1.11

0.06

1.4

1.6

11.99

14.56

umol/l

1.03

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

105

0.86

0.06

1.3

1.6

9.79

11.71

umol/l

—

Follicular lymphoma, hilmo

105

0.86

0.06

1.3

1.6

14.38

14.40

umol/l

—

Amblyopia ex anopsia

119

1.09

0.06

1.3

1.5

14.17

10.95

umol/l

0.74

109

Acute suppurative otitis media

107

1017

0.98

0.05

1.4

1.5

10.90

11.15

umol/l

0.15

100

964

Labour and delivery complicated by umbilical cord complications

149

1.07

0.05

1.3

1.4

12.76

10.45

umol/l

0.75

140

Sacroiliitis, not elsewhere classified

149

1.07

0.05

1.4

1.5

10.80

10.51

umol/l

0.07

138

Injuries to the wrist and hand

440

2893

1.01

0.04

1.4

12.26

12.33

umol/l

0.08

418

2738

Impingement syndrome of shoulder

726

0.98

0.04

1.3

1.5

13.78

13.15

umol/l

0.28

681

Postprocedural musculoskeletal disorders, not elsewhere classified

199

1.06

0.04

1.7

1.6

12.21

13.02

umol/l

0.32

187

Disorders of continuity of bone

338

1.04

0.04

1.3

1.5

14.10

12.10

umol/l

0.85

318

malignant neoplasm of male genital organs, including Hilmo

526

0.98

0.04

1.3

1.5

14.96

15.17

umol/l

0.09

486

malignant neoplasm of male genital organs

515

0.98

0.04

1.4

1.5

15.21

15.16

umol/l

0.02

475

Malignant neoplasm of bladder

139

0.93

0.03

1.2

1.5

15.15

16.62

umol/l

0.22

125

Biguanides

389

2333

1.01

0.03

1.3

1.4

14.04

12.22

umol/l

4.54

354

2223

Anti-inflammatory and antirheumatic products, non-steroids

126

626

1.01

0.03

1.6

1.4

12.47

13.66

umol/l

1.04

116

600

LSIL lesion of the cervix uteri

370

0.97

0.03

1.3

1.4

10.26

9.78

umol/l

0.15

350

Sulfonylureas

677

0.99

0.02

1.2

1.5

16.48

14.40

umol/l

1.70

638

Benign neoplasm: Skin of trunk

128

0.94

0.02

1.3

1.5

11.39

12.01

umol/l

0.13

120

Glaucoma

181

1547

0.99

0.02

1.4

12.45

13.73

umol/l

1.82

167

1452

Tonsillectomy and adenotomy

251

1755

0.99

0.02

1.3

1.4

10.52

11.28

umol/l

1.43

240

1669

Salpingitis and oophoritis

539

0.98

0.02

1.6

1.4

12.60

11.33

umol/l

0.50

508

Pathological resorption of teeth

107

0.93

0.02

1.2

1.6

11.58

12.43

umol/l

—

LeFortI or BSSO operation

133

1.05

0.01

1.5

1.6

9.93

10.39

umol/l

0.19

125

Poor fetal growth

427

0.98

0.01

1.3

1.4

10.00

9.38

umol/l

0.36

403

Alzheimer disease, including avohilmo

635

0.99

0.01

1.4

14.64

15.17

umol/l

0.22

586

Pediculosis, acariasis and other infestations

194

1.03

0.00

1.3

1.6

12.47

12.49

umol/l

0.01

185

Spontaneous abortion

167

1113

1.00

0.00

1.2

1.4

11.01

10.83

umol/l

0.13

159

1061

Fracture at wrist and hand level

138

1377

1.00

0.00

1.4

12.83

12.48

umol/l

0.23

133

1296

Adenocarcinoma and papilloma adenocarcinoma of rectum

242

0.99

0.00

1.3

1.5

14.56

14.64

umol/l

0.02

219

Complications predominantly related to the puerperium

924

1.00

0.00

1.4

9.62

10.45

umol/l

0.68

882

Diabetic maculopathy

360

1.00

0.00

1.3

1.4

13.81

14.43

umol/l

0.16

333

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

252

0.99

0.00

1.2

1.5

14.47

14.56

umol/l

0.02

228

Juvenile arthritis (FINNGEN)

141

0.99

0.00

1.3

1.4

12.52

9.78

umol/l

0.49

132

Propionic acid derivatives

124

626

1.00

0.00

1.6

1.4

12.20

13.66

umol/l

1.33

115

600

Tooth agenesis EXCLUDE clefts and syndromes

128

1.01

0.00

1.5

8.11

10.14

umol/l

1.63

122

Follicular cysts of skin and subcutaneous tissue

605

0.99

0.00

1.2

1.5

13.94

12.70

umol/l

0.62

568

Malignant neoplasm of prostate

472

1.00

0.00

1.4

1.5

14.89

15.52

umol/l

0.32

434

Muscle strain

1.04

0.00

1.3

1.5

14.08

11.47

umol/l

—

Struck by thrown, projected or falling objec

176

1.02

0.00

1.2

1.6

11.50

12.43

umol/l

0.38

166

Recurrent dislocation of patella

162

0.99

0.00

1.3

1.5

14.44

10.11

umol/l

0.94

150

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

117

1172

1.00

0.00

1.4

12.76

11.89

umol/l

0.59

110

1110

Viral conjunctivitis, including avohilmo

113

0.97

0.00

1.5

9.24

11.17

umol/l

1.26

103

Primary open-angle glaucoma, strict

681

1.00

0.00

1.4

11.54

14.53

umol/l

4.04

638

Other noninflammatory disorders of cervix uteri

127

1.02

0.00

1.3

11.77

12.08

umol/l

0.06

120

Secondary sideroblastic anaemia

0.00

0.0

2.2

—

17.02

—

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

0.00

0.0

1.5

—

17.83

—

Erythema annulare centrifugum

0.00

0.0

1.8

—

16.18

—

Assault by hanging, strangulation and suffocation

0.00

0.0

1.7

—

10.86

—

Exposure to ignition of highly flammable material

0.00

0.0

2.1

—

10.00

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.99

0.00

1.1

1.3

9.61

9.08

umol/l

—

Epileptic seizures related to drugs

0.00

0.0

1.6

—

11.88

—

Oligomenorrhoea

0.98

0.00

1.4

1.3

10.06

10.45

umol/l

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.4

—

11.00

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.0

2.8

—

10.22

—

Myiasis, including avohilmo

0.00

0.0

1.8

—

17.22

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

2.3

—

16.52

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

-0.00

0.0

1.9

—

16.30

—

Melanoma in situ of scalp and neck

0.00

-0.00

0.0

2.1

—

15.73

—

Keratoconus

0.95

-0.00

1.1

1.8

10.29

11.88

umol/l

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

-0.00

0.0

2.0

—

11.60

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

-0.00

0.0

1.9

—

9.00

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.6

—

14.40

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.91

-0.00

1.0

1.6

14.90

13.02

umol/l

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

-0.00

0.0

1.5

—

11.67

—

Frontotemporal dementia

0.00

-0.00

0.0

1.7

—

14.76

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

1.2

—

17.80

—

Disorders of puberty, other/unspecified

0.00

-0.00

0.0

1.4

—

8.88

—

Necrobiosis lipoidica, not elsewhere classified

0.00

-0.00

0.0

1.3

—

12.75

—

Multiple superficial injuries of ankle and foot

0.00

-0.00

0.0

1.4

—

8.86

—

0.93

-0.00

1.1

1.7

12.33

8.72

umol/l

—

Enteropathogenic Escherichia coli infection

0.00

-0.00

0.0

1.2

—

11.17

—

Factitial dermatitis

0.00

-0.00

0.0

1.2

—

15.50

—

Disorder of mineral metabolism, other/unspecified

0.00

-0.00

0.0

2.2

—

15.42

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.6

—

13.00

—

Contact urticaria

0.00

-0.00

0.0

1.3

—

9.67

—

Benign neoplasm: Heart

0.00

-0.00

0.0

1.3

—

11.29

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

-0.00

0.0

1.7

—

17.44

—

Malignant neoplasm of penis

0.00

-0.00

0.0

1.8

—

19.11

—

Airway disease due to specific organic dust

0.00

-0.00

0.0

1.5

—

9.67

—

Benign neoplasm: Lacrimal gland and duct

0.00

-0.00

0.0

1.2

—

12.20

—

Moderate mental retardation

0.00

-0.00

0.0

1.4

—

10.57

—

Operations 1 for CAVS

0.00

-0.00

0.0

1.8

—

15.02

—

Polyglandular dysfunction

0.00

-0.00

0.0

1.2

—

18.40

—

Tick-borne viral encephalitis

0.00

-0.00

0.0

1.4

—

13.00

—

0.90

-0.00

1.1

1.6

11.66

9.34

umol/l

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

-0.00

0.0

1.7

—

14.68

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

2.0

—

8.94

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.2

—

13.00

—

Lesion of sciatic nerve

0.98

-0.00

1.9

1.6

15.49

13.90

umol/l

—

Myiasis

0.00

-0.00

0.0

1.8

—

17.22

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

-0.00

0.0

2.0

—

14.22

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

13.13

—

Other disorders of bone development and growth

0.00

-0.00

0.0

1.8

—

10.80

—

Epiphora

1.00

-0.00

1.0

1.7

9.29

11.66

umol/l

—

Primary angle-closure glaucoma

0.95

-0.00

1.6

1.5

12.89

15.28

umol/l

—

Use of glatiramer acetate

1.00

-0.00

1.2

1.3

15.80

10.04

umol/l

—

Pityriasis alba

0.00

-0.00

0.0

2.8

—

14.42

—

Lichenoid drug reaction

0.00

-0.00

0.0

1.2

—

13.00

—

Transient acantholytic dermatosis [Grover]

0.00

-0.00

0.0

1.8

—

16.18

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

2.1

—

9.43

—

Other specified/unspecified spondylopathies

0.98

-0.00

1.0

1.6

13.17

13.97

umol/l

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

-0.00

0.0

1.2

—

15.00

—

Toxic erythema

0.00

-0.00

0.0

1.3

—

13.17

—

0.00

-0.00

0.0

1.6

—

6.82

—

Hair colour and hair shaft abnormalities

0.00

-0.00

0.0

1.6

—

13.71

—

Neonatal jaundice from other and unspecified causes

0.91

-0.00

1.0

1.7

11.56

8.08

umol/l

—

Benign neoplasm of thyroid gland

1.00

-0.00

1.0

1.6

10.29

11.97

umol/l

—

Lichen planopilaris

0.00

-0.00

0.0

1.8

—

8.95

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

-0.00

0.0

2.0

—

8.02

—

Other acantholytic disorders

0.00

-0.00

0.0

1.7

—

15.87

—

Aortic stenosis, including avohilmo

0.00

-0.00

0.0

2.1

—

13.64

—

Imperforate hymen

0.00

-0.00

0.0

2.0

—

10.60

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

-0.00

0.0

1.8

—

10.40

—

Meningitis, viral

0.00

-0.00

0.0

2.0

—

14.79

—

Other secondary coxarthrosis

0.93

-0.00

2.0

1.4

17.75

13.14

umol/l

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

-0.00

0.0

2.2

—

13.17

—

Other specified/unspecified disorders of tympanic membrane

0.00

-0.00

0.0

1.9

—

10.50

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.8

—

10.40

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.90

-0.00

1.0

1.6

9.61

11.35

umol/l

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.8

—

16.68

—

Chronic myringitis

0.00

-0.00

0.0

1.1

—

13.38

—

Absence of one kidney

0.00

-0.00

0.0

2.3

—

11.33

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

-0.00

0.0

1.4

—

9.20

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

-0.00

0.0

1.8

—

11.80

—

Labyrinthine fistula

0.00

-0.00

0.0

1.7

—

13.16

—

Other congenital malformations of skull and face bones

0.00

-0.00

0.0

1.9

—

8.29

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.9

—

11.57

—

Other degenerative disorders of eyelid and periocular area

0.00

-0.00

0.0

1.6

—

13.80

—

Open wound of abdomen, lower back and pelvis

0.94

-0.00

1.2

1.8

10.96

11.93

umol/l

—

Upper arm

0.00

-0.00

0.0

2.0

—

16.42

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

2.0

—

9.44

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.9

—

10.14

—

Interstitial cystitis (chronic), drug-induced

0.00

-0.00

0.0

1.6

—

15.01

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

-0.00

0.0

2.0

—

11.40

—

Contact with other hot fluids

0.90

-0.00

1.3

1.6

11.97

12.26

umol/l

—

Other specified/unspecified disorders of ear

0.00

-0.00

0.0

1.8

—

11.89

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.7

—

11.43

—

Food allergy

0.00

-0.00

0.0

2.0

—

10.40

—

Sleepwalking [somnambulism]

0.00

-0.00

0.0

1.6

—

11.67

—

Congenital myopathies

0.00

-0.00

0.0

1.2

—

9.17

—

Bacterial meningoencephalitis and meningomyelitis

0.00

-0.00

0.0

2.6

—

14.22

—

Occupant of streetcar injured in transport accident

0.00

-0.00

0.0

1.6

—

10.60

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.9

—

9.29

—

Retarded development following protein-energy malnutrition

0.00

-0.00

0.0

1.6

—

10.00

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

1.4

—

12.20

—

Myasthenia gravis, drug-induced

0.00

-0.00

0.0

1.2

—

13.00

—

Pregnant state, incidental

0.00

-0.00

0.0

2.4

—

10.30

—

Sleep terrors [night terrors]

0.00

-0.00

0.0

2.2

—

11.33

—

Choroidal detachment

0.00

-0.00

0.0

1.8

—

11.35

—

Central nervous system disorder causing precocious puberty

0.00

-0.00

0.0

2.4

—

8.40

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.2

—

12.00

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.2

—

12.33

—

Vitreous prolapse

0.00

-0.00

0.0

1.6

—

11.00

—

Adrenogenital disorders

0.00

-0.00

0.0

2.0

—

20.83

—

Chromomycosis and phaeomycotic abscess, including avohilmo

0.00

-0.00

0.0

1.6

—

9.71

—

Pleural plaque without asbestos

0.91

-0.00

1.0

1.6

18.54

16.23

umol/l

—

Colour vision deficiencies

0.00

-0.00

0.0

1.8

—

9.25

—

Renal agenesis and other reduction defects of kidney

0.00

-0.00

0.0

2.4

—

10.50

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Homocysteine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS